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6ABBREVIATIONS
AA rats alcohol preferring (Alko, Alcohol) rat line
AcH acetaldehyde
ADH alcohol dehydrogenase
AHMD alcoholic heart muscle disease
Akt  a serine/threonine protein kinase also known as protein kinase B
ALDH acetaldehyde dehydrogenase
ANA rats alcohol avoiding (Alko, Non-Alcohol) rat line
Ang II angiotensin II
ANP atrial natriuretic peptide
ATP adenosine triphosphate
Bax gene for proto-oncogene bax, a proapoptotic member of the 
 bcl-2 family
Bcl-2 gene for B cell lymphoma-2 protein, an antiapoptotic member of  
 the bcl-2 family





cDNA complementary deoxyribonucleic acid
CNS central nervous system
cRNA complementary ribonucleic acid
DNA deoxyribonucleic acid
E ethanol
ELISA enzyme linked immunosorbent assay
FAEE fatty acid ethyl esters
LV  left ventricle
mRNA messenger ribonucleic acid
NAD+ nicotinamide adenine dinucleotide
NADP+ nicotinamide adenine dinucleotide phosphate




p21 cyclin-dependent kinase inhibitor, also known as ras, waf1, cip1
p53 gene for protein p53, a tumor suppressor gene
PCR polymerase chain reaction
RIA radioimmunoassay
RT reverse transcription
RT-PCR reverse transcription of RNA followed by polymerase chain 
 reaction
S.E.M. standard error of the mean
SHR spontaneously hypertensive rat line
TNF-alpha tumor necrosis factor-alpha
WKY normotensive Wistar-Kyoto ratline
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8INTRODUCTION
Although benefi cial effects of mild to moderate ethanol consumption have 
been reported in relation to cardiovascular diseases (for references see Im-
hof & Koenig 2003), alcohol abuse has been shown to be a major cause of 
non-ischemic cardiomyopathy in Western society. Outcome in those affected 
is poor, and mortality can reach 40-60% within three to fi ve years (Dancy & 
Maxwell 1986; Schoppet & Maisch 2001; Piano 2002). However, the biochem-
ical and molecular mechanisms involved in the pathological effects of ethanol 
and its highly reactive metabolite, acetaldehyde, remain largely unknown.
During the last decade, roles of apoptosis and apoptosis regulating genes have 
been described in relation to many types of ethanol induced organ damage, for 
example in the liver (Goldin et al. 1993). Apoptosis is a stepwise, tightly regu-
lated mechanism through which damaged or unwanted cells are eliminated 
without evoking an infl ammatory response (Bishopric et al. 2001). However, 
excessive apoptosis has been associated with many cardiac diseases, including 
cardiomyopathy. Adult cardiomyocytes are terminally differentiated and, once 
destroyed, are sparsely replaced. Their loss can therefore contribute to func-
tional decline of the myocardium and lead to heart disease (Gill et al. 2002).
The aim of the work described here was to study the effects of ethanol and 
acetaldehyde on apoptosis and some genes associated with cardiac cell adapta-
tion, apoptosis and hypertrophy in the rat heart, in vivo and in vitro.
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1. ETHANOL AND ACETALDEHYDE METABOLISM
1.1. Pathways of alcohol metabolism
In healthy individuals ethanol is mostly oxidized by alcohol dehydrogenase 
(ADH). ADH is a NAD+(NADP+)-dependent enzyme expressed as numerous 
isoenzymes, and is most abundant in liver tissue (Jörnvall & Höög 1995). Al-
most all organs are capable of oxidizing small amounts of ethanol. Trace amounts 
of ADH have also been found in the heart (for references see Regan 1984).
The microsomal ethanol oxidizing system is an ethanol-inducible, 
NADPH-dependent pathway for ethanol oxidation. Expression of genes for 
these mono-oxygenases has been demonstrated in the heart, predominantly in 
the right side (Thum & Borlak 2000).
A third pathway of ethanol oxidation in mammals involves catalase, a hy-
drogen-peroxide-dependent enzyme that acts as an intracellular antioxidant 
(Bai & Cederbaum 2001). Peroxisomes containing catalase have been found in 
the myocardium in mice, and in the hearts of several other mammalian spe-
cies, including primates. Increased cardiac catalase activity has been observed 
in rats that have ingested ethanol over long periods, and this has been inter-
preted as a protective compensatory mechanism. In rats, chronic inhibition of 
catalase during six weeks of ethanol consumption results in substantial histo-
logic abnormality in the myocardium (for references see Regan 1984).
A nonoxidative pathway of ethanol metabolism has been identifi ed in the 
heart. This metabolic pathway results in potentially toxic products known as 
fatty acid ethyl esters (FAEE). These are thought to accumulate in cell mi-
tochondria, facilitate uncoupling of oxidative phosphorylation and result in 
ineffi ciency of energy production, leading to cell damage. FAEEs are rapidly 
synthesized by FAEE synthase (Beckemeier & Bora 1998). Ethanol exposure 
results in signifi cant increases in levels of cardiac FAEE when ethanol reacts 
with nonesterifi ed fatty acids (Calabrese et al. 2001).
Oxidation of acetaldehyde to acetate is catalysed by acetaldehyde dehydro-
genase (ALDH), a NAD+(NADP+)-dependent enzyme. There are four to fi ve 
classes of ALDH, including both constitutive and inducible isoenzymes. A low 
Km (1 µmol/l) ALDH activity has been found in rat heart mitochondria but 
an acetaldehyde concentration of 50 µmol/l or higher is necessary to reduce tis-
sue NAD+ in the perfused heart (Peuhkurinen et al. 1983). 
1.2. Gender differences in metabolism
Women develop, for example, alcohol-related cirrhosis and alcohol-related 
hepatitis at a younger age and after a lower cumulative alcohol intake than 
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men. Differences between males and females in connection with ethanol-re-
lated pharmacokinetics could explain observed gender differences  concerning 
blood concentrations and toxicity of ethanol (Thomasson 1995). The rate of 
gastric emptying of alcohol is lower in women than in men, and fi rst-pass me-
tabolism is less extensive in women than in men because of lower ADH ac-
tivity in the female stomach. In consequence, the bioavailability of ethanol is 
higher in women than in men. The smaller volume of distribution for ethanol 
in the female body results in higher blood alcohol levels than in men. Blood 
alcohol levels are therefore higher and more sustained in women than in men 
after a given dose of ethanol per kg body weight. However, the rate of etha-
nol oxidation in the liver is higher in women than in men. The maximal rate 
of elimination is 10% higher in women than in men (Baraona et al. 2001). 
Women therefore exhibit higher ethanol-induced plasma acetaldehyde levels 
than men, which may result in tissues being exposed to higher levels of acetal-
dehyde (Thomasson 1995). It has also been suggested that estrogen-related el-
evations of acetaldehyde levels may help explain gender differences relating to 
the adverse effects of ethanol (Eriksson et al. 1996).
2. EFFECTS OF ETHANOL AND ACETALDEHYDE ON HEART   
 MUSCLE
2.1. Mechanisms of cardiac muscle adaptation to ethanol and   
 acetaldehyde 
Mitochondrial membrane damage may be one of the most important effects 
of alcohol on the heart. Ethanol changes mitochondrial membrane permeabil-
ity and function, depresses mitochondrial respiration (for references see Regan 
1984), inhibits mitochondrial protein synthesis (Dancy & Maxwell 1986) and 
induces oxidative stress (Reinke et al. 1987). 
Both ethanol and acetaldehyde affect cardiac protein synthesis. In one 
study, short-term exposure to acetaldehyde but not to ethanol reduced cardiac 
protein synthesis (Schreiber et al. 1972). In other studies reductions in car-
diac protein synthesis in response to short-term administration of ethanol have 
been observed (Siddiq et al. 1993; Preedy et al. 1994). More prolonged inges-
tion of ethanol has been shown to either inhibit (Tiernan et al. 1985; Vary et 
al. 2001) or increase protein synthesis (Preedy et al. 1994). Animals that have 
inhaled acetaldehyde for 21 days exhibit no diminution in the rate of synthesis 
of cardiac proteins (Auton & Ward 1986).
Ethanol increases biomembrane fl uidity and selectively alters ionic con-
ductance (Dancy & Maxwell 1986). For example, ethanol administration re-
versibly inhibits both uptake and binding of calcium by isolated cardiac sar-
coplasmic reticulum in vitro, and by mitochondria in vivo, and acetaldehyde, 
but not ethanol, inhibits calcium-activated myofi brillar ATPase (Bing 1978). 
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Evidence that acetaldehyde plays a role in alcohol-induced cardiomyopa-
thy stems almost entirely from experiments in animals. Consideration has 
been given to whether there may be an immunological basis for progression of 
alcoholic cardiomyopathy. Acetaldehyde is extremely reactive. It binds cova-
lently to structural and contractile proteins. It forms protein adducts, which 
may cause DNA and cell malfunction through effects on transcription and/or 
by stimulating immune responses (Eriksson 2001; Niemelä 2001). Protein ad-
ducts are generated both in heart and skeletal muscle in response to either 
acute (Niemelä et al. 2002; Niemelä et al. 2003) or chronic (Worrall et al. 
2000; Worrall et al. 2001) ethanol exposure. Thirty-three per cent of patients 
with alcoholic heart muscle disease (AHMD) exhibit antibodies against car-
diac protein-acetaldehyde adducts (Harcombe et al. 1995). Interesting work 
has been undertaken using transgenic mice with cardiac-specifi c over-expres-
sion of ADH. After ethanol intake cardiac acetaldehyde levels are four times 
greater than in control mice, elevated ANP gene expression, cardiac lipid and 
protein damage, hypertrophy and contractile damage, all indicative of AHMD 
(Liang et al. 1999; Hintz et al. 2003). Evidence relating to human cardiac in-
jury comes from observations of simultaneous consumption of alcohol and use 
of cyanamide or disulfi ram (acetaldehyde dehydrogenase inhibitors) (for review 
see Eriksson 2001). Administration of acetaldehyde is particularly problematic 
because of its extreme chemical and biological reactivity, and very high toxic-
ity (Preedy & Richardson 1994).
In rats increases in heart weight are evident after only 48 hours of exposure 
to ethanol. After 96 hours of exposure increases of more than 20% over control 
values are observed (Adams & Hirst 1986). Chronic administration of alcohol 
for 12 weeks to eight months results in decreased heart weight (Capasso et al. 
1991; Vary et al. 2001). In some studies heart weight to body weight ratios 
do not change (Capasso et al. 1991), as in others ratios decrease (Brown et al. 
1996). In middle-aged men heart weight increases with increasing daily alco-
hol use (Kajander et al. 2001). Acetaldehyde exposure for 21 days signifi cantly 
increases heart weight as a percentage of body weight (Auton & Ward 1986). 
Recent data indicate that both acute (Krenz et al. 2002) and chronic (three 
to 12-weeks) (Miyamae et al. 1997) administration of ethanol can have a pro-
tective effect on the heart that resembles preconditioning. Results of studies 
performed both in vivo and in vitro show that hearts that are exposed to etha-
nol before ischemia recover better functionally and exhibit less myocyte dam-
age after ischemia than hearts that are not exposed to ethanol. However, if 
ethanol remains present during ischemia it can nullify its own protective effect 
and the protection given by ischemic preconditioning. The anti-protective and 
protective effects occur at similar threshold levels, of about 5 mmol/l of etha-
nol (Krenz et al. 2002). It has been suggested that Akt, a serine/threonine pro-
tein kinase, may be a downstream mediator of the benefi cial effects of ethanol 
on myocardial function (Zhou et al. 2002).
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2.2. Alcoholic cardiac muscle disease
2.2.1. General
Alcohol abuse has been found to be a major cause of non-ischemic cardiomy-
opathy in Western society. Alcoholic heart muscle disease (AHMD) accounts for 
about 3.8% of all cases of cardiomyopathy (Piano 2002). There are no specifi c 
immunohistochemical, immunological or other criteria for diagnosis of AHMD. 
Diagnosis is often simply presumptive, usually by exclusion. Like other dilat-
ed cardiomyopathies, AHMD is characterized by increased left ventricular (LV) 
mass, dilatation of the ventricles, wall thinning and ventricular dysfunction. The 
diagnosis is established if the sole causative agent is consumption of more than 
80 to 90 g of ethanol a day for more than fi ve to ten years (Urbano-Marquez et al. 
1989; Preedy & Richardson 1994; Piano 2002). Some individuals are peculiarly 
resistant to AHMD. Little is known about the factors determining the severity of 
AHMD in individual alcoholics (Kajander et al. 2001). 
It has been suggested that the mainstay of treatment should be permanent 
abstinence from alcohol (Piano 2002). However, Nicolas et al. (2002) report 
that both abstinence and controlled drinking are similarly effective in patients 
with AHMD in promoting improvement in cardiac function. They provide 
preliminary evidence that there is a threshold in relation to alcohol consump-
tion, probably about 60 g per day (four standard drinks), below which the 
myocardium suffers no damage. No studies have been carried out in which 
pharmacotherapy has been specifi cally investigated in patients with AHMD. 
Guidelines recommend the use of agents such as angiotensin-converting en-
zyme inhibitors and beta-adrenergic blockers that inhibit the LV remodelling 
process, and treat the patient’s symptoms (Piano 2002). The prognosis in pa-
tients with AHMD is poor. Heart disease is an important cause of death in 
chronic alcoholics. Mortality is 40 to 60% within three to fi ve years of diag-
nosis in a non-abstinent group (Dancy & Maxwell 1986; Schoppet & Maisch 
2001; Piano 2002). 
2.2.2. Gender differences in alcoholic heart muscle disease
In the United States, in both sexes, long-term heavy consumption of alcohol is 
the leading cause of nonischemic dilated cardiomyopathy. Women account for 
approximately 14% of cases of AHMD. Death rates from AHMD are greater 
in men than in women (Piano 2002). However, AHMD is equally common 
in chronically alcoholic women and men, even though the mean amount of 
ethanol ingested by female alcoholics has been found to be only 60% of that 
in male alcoholics (Fernandez-Sola & Nicolas-Arfelis 2002). Cardiac functional 
class and left ventricular mass index are lower in alcoholic women than al-
coholic men (Fernandez-Sola et al. 1997). In a study by Kupari & Koskinen 
(1992) no statistically signifi cant differences were found in relation to LV anat-
omy or function between alcoholic men and women, except for differences re-
lated to body size.
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3. APOPTOSIS IN THE HEART
3.1. General mechanisms
Apoptosis was originally defi ned as a form of cell death with distinct phases of 
ultrastructural morphological features, such as nuclear chromatin condensation 
and cellular shrinkage (Majno & Joris 1995). However, apoptosis is probably 
best defi ned functionally, as a stepwise, tightly regulated mechanism for elimi-
nating damaged or superfl uous cells without an infl ammatory response (Bisho-
pric et al. 2001). Apoptosis occurs normally during development and tissue 
turnover, and in connection with functioning of the immune system. There are 
various points at which it can be regulated (Gill et al. 2002). At the cellular 
level, there is normally a balance between apoptotic and anti-apoptotic signals. 
Cell death occurs in response to a shift in this balance (Hunter & Chien 1999).
Two independent pathways lead to induction of apoptosis, with limited 
cross-talk between them. The type-I or ‘extrinsic’ apoptotic pathway is mediated 
by external factors that bind to members of the death receptor superfamily, of 
which tumor necrosis factor (TNF) receptor type 1 is an example. Specifi c bind-
ing by TNF-alpha induces receptor aggregation, leading to cleavage and activa-
tion of caspase 8 from procaspase 8, which in turn activates caspase 3. The second 
major pathway for apoptosis is the ‘intrinsic’, or type-II, mitochondria-depend-
ent pathway. Mitochondria contain a number of highly lethal substances that can 
initiate apoptosis when released into the cytosol. Under conditions that remain 
partly mysterious, cytochrome c is released from mitochondria and forms a com-
plex with procaspase 9 and its cofactor apoptotic protease-activating factor 1. In 
the presence of suffi cient ATP, caspase 9 then undergoes a conformational change 
that produces the active ‘apoptosome’. The apoptosome activates caspase 3 and 
execution of the apoptotic program follows (Bishopric et al. 2001). Some regula-
tory mechanisms relating to apoptosis are shown in Figure 1.
Adult cardiomyocytes are terminally differentiated cells. Their loss can 
contribute to functional decline of the myocardium, leading to heart disease. 
Examination of human heart tissue has revealed apoptosis in conditions such 
as cardiomyopathy (Gill et al. 2002) and end-stage heart failure (Nadal-Gi-
nard et al. 2003). Apoptosis is stimulated in myocytes by circumstances that 
include ischemia/reperfusion, hypoxia, presence of reactive oxygen species, 
calcium overload, mechanical factors (excessive stretching) and elevated lev-
els of humoral factors, including norepinephrine and angiotensin II (Ang II) 
(Dispersyn & Borgers 2001). The extent of apoptosis has been found to vary 
widely. It depends on the model used and the area at risk examined (Kang & 
Izumo 2000). For example, in fatal myocarditis about 2% of cardiomyocytes 
are apoptotic (Kytö et al. 2004). In most studies of apoptotic cell death in end-
stage heart failure variable low levels of apoptosis (0.1 to 0.5% of myocytes) 
have been recorded, and levels in non-failing myocardium have been negligi-
ble. Conclusive evidence that cardiac myocyte apoptosis alone can cause cardiac 
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Figure 1.  Schematic representation of the apoptotic cascade in heart muscle. 
Two independent pathways lead to induction of apoptosis. Type-I or ‘extrinsic’ 
apoptotic pathway is mediated by external factors that bind to members of the 
death receptor superfamily, of which tumor necrosis factor (TNF) receptor type 
1 is an example. Specifi c binding by TNF-alpha leads to activation of caspase 
8 from procaspase 8, which in turn activates caspase 3. The second major path-
way for apoptosis is the mitochondria-dependent pathway. Mitochondria contain 
a number of highly lethal substances that can initiate apoptosis when released 
into the cytosol. Anti-apoptotic proteins, including bcl-2, can inhibit apoptosis 
through mitochondria. Bax, on the other hand, is an important mediator of mi-
tochondrial apoptotic process. When cytochrome c is released from mitochondria 
it forms a complex with procaspase 9 and its cofactor apoptotic protease-activat-
ing factor 1 producing an active ‘apoptosome’. The apoptosome activates caspase 
3 and execution of the apoptotic program follows. p53 regulates both transcrip-
tion and function of bcl-2, bax and p21 genes. It is possible that Akt, a protein 
kinase, is involved in this regulatory process.
15
failure has been provided by studies involving genetically manipulated mouse 
models (Nadal-Ginard et al. 2003; Engel et al. 2004). Modest levels of myocyte 
apoptosis (affecting 23 myocytes per 105 nuclei as opposed to 1.5 myocytes per 
105 nuclei in controls) are suffi cient to cause lethal dilated cardiomyopathy 
(Wencker et al. 2003). Apoptosis has also attracted considerable attention as a 
potentially reversible cause of cardiac functional deterioration.
3.2. Hypertrophy, cell death and cell survival
Cardiac remodelling is now recognized to be an important aspect of cardiovas-
cular disease progression. Cardiac remodelling may be defi ned as genome ex-
pression, molecular, cellular and interstitial changes that manifest themselves 
clinically as changes in the size, shape and function of the heart following 
cardiac insult. Cellular changes include, for example, myocyte hypertrophy, 
necrosis, apoptosis and fi brosis. The initial remodelling phase may, to some 
extent, be regarded as benefi cial. There are no data indicating when transition 
from possibly adaptive to maladaptive remodelling occurs (Cohn et al. 2000). 
Progressive remodelling, irrespective of the criteria used in its measurement, 
may always be considered deleterious and is associated with poor prognosis 
(Gaudron et al. 1993).
Left ventricular hypertrophy represents both an adaptive response to in-
creased cardiac workload and a precursor of heart failure (Condorelli et al. 
1999). Although initially compensatory, myocardial hypertrophy is an im-
portant risk factor of subsequent cardiac morbidity and mortality (Hunter & 
Chien 1999). Adaptive hypertrophic response is characterized by increases in 
masses and volumes of individual myocytes, resulting in increases in heart 
weight without increases in numbers of cardiomyocytes (Morgan et al. 1987). 
Recent observations in humans and animals suggest that large myocytes lose 
ability to increase in size, and that telomeric shortening becomes apparent in 
hypertrophic old myocytes (Anversa et al. 2002). Once a critical level of short-
ening occurs, sensors for DNA damage are triggered and cell-cycle arrest or 
apoptosis is induced (for references see Igney & Krammer 2002). In the human 
heart, telomere shortening with age may be a critical biological determinant of 
heart failure in the elderly (Leri et al. 2003). Evidence of myocyte apoptosis in 
association with left ventricular hypertrophy has been reported in relation to 
both experimental and clinical cardiac hypertrophy (Hunter & Chien 1999).
Cell death can occur in a destructive, uncontrolled manner via necrosis or 
controlled manner via apoptosis. Apoptosis occurs concomitantly with necrosis 
for example, in the failing heart (Guerra et al. 1999). It is often suggested that 
the two types of cell death can be triggered by the same factors but the degree 
of the insult determines whether the jeopardized cell will die by necrosis or 
apoptosis (Dispersyn & Borgers 2001). ‘Strong’ cell death stimuli usually lead 
to necrosis due to irreversible mitochondrial damage and energetic catastrophe. 
But ‘mild’ death stimuli may damage a subpopulation of mitochondria only; 
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resulting in apoptosis if the level of ATP produced by the spared mitochondria 
is high enough to activate the apoptosome (Martinou & Green 2001). Many 
stimuli, for example work overload and Ang II can result in both hypertrophy 
and apoptosis (Condorelli et al. 1999; Anversa et al. 2000; Zhang et al. 2000a). 
Sublethal injury on the other hand is likely to trigger a number of protec-
tive mechanisms, which can be collectively termed ‘programmed cell survival’ 
(Dispersyn & Borgers 2001). Preconditioning and hibernation are typical ex-
amples of such an adaptive response (Kloner et al. 1998). Findings therefore 
suggest a situation in which similar signal transduction pathways are involved 
in cardiomyocyte preconditioning, hypertrophy and apoptosis. They may rep-
resent responses to various degrees of cardiac insult and different phases of a 
single process (Condorelli et al. 1999; Sabri et al. 2002). Cardiac response to a 
particular insult will also depend on the state of the organ before insult. For 
example, cyclic mechanical stretching results in apoptosis in myocytes from 
young rats but necrosis in myocytes from old rats (Husse et al. 2003). It is in-
teresting that cardiac resistance to insult is increased through modifi cation of 
its gene expression (Kloner et al. 1998; Hochhauser et al. 2003). 
3.3. Gender differences 
Gender differences may infl uence susceptibility to apoptosis in the human 
heart. Percentages of apoptotic cardiomyocytes have been found to be two 
(Guerra et al. 1999) to three times (Mallat et al. 2001) higher in men than 
in women. Heart failure results in 13-fold and 27-fold increases in necrosis 
and 35-fold and 85-fold increases in apoptosis in women and men, respectively 
(Guerra et al. 1999). Ageing does not lead to myocyte loss and myocyte reac-
tive hypertrophy in women. In contrast, men lose nearly 1% of their myocytes 
per year: between 17 and 89 years of age the male heart loses 45 million myo-
cytes per year from the left ventricle. Myocyte loss is accompanied by progres-
sive increases in average myocyte volume. This reactive hypertrophic response 
compensates, in part at least, for the destruction in muscle mass (Olivetti et al. 
1995). In 50 patients with ischemic cardiomyopathy, the heart weight index 
is signifi cantly greater in men than in women. No similar difference is seen 
in patients with idiopathic cardiomyopathy. The differences between ischemic 
and idiopathic cardiomyopathy suggest that gender infl uences myocardial re-
sponse to injury (Crabbe et al. 2003).
Telomerase replaces telomeric repeat DNA lost during the cell cycle, re-
storing telomere length.  Telomerase activity is detectable in both young and 
aging ventricular myocytes. However, aging decreases telomerase activity by 
31% in male myocytes. In female myocytes activity of this enzyme increases 
by 72%. This different adaptation in the two sexes may be relevant to the 
myocyte loss that occurs in men as they age (Leri et al. 2000a). There is also a 
similar difference between the sexes in relation to myocardial activation of Akt, 
the serine/threonine protein kinase that regulates a wide range of physiological 
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responses, including metabolism, gene transcription and apoptosis (Camper-
Kirby et al. 2001). Female hypertrophic hearts also express higher levels of, 
for example, alpha and beta-myosin heavy-chain mRNA and collagen type-I 
transcripts than male hypertrophic hearts (Rosenkranz-Weiss et al. 1994). In 
contrast, Zhao et al. (2002) have reported that cardiac fi broblasts from male 
rats express higher levels of the transcription factors c-jun and NF-kB than 
fi broblasts from female rats. In general, it has been reported that estrogens 
inhibit cardiac hypertrophy. However, this inhibition may not always be ben-
efi cial, because a hypertrophic response to increased cardiac load is primarily 
adaptive (Vuolteenaho & Ruskoaho 2003). Estrogen replacement therapy after 
myocardial infarction in mice reduces infarct size but increases ventricular re-
modelling and mortality (van Eickels et al. 2003). Both in vivo and in vitro 
apoptosis is decreased and Akt activated (Patten et al. 2004).
4. ETHANOL AND APOPTOSIS 
4.1. Heart
Ethanol decreases the viability of primary cultured cardiomyocytes and in-
creases apoptosis, dose-dependently (Chen et al. 2000). In vivo, prenatal ex-
posure to ethanol increases myocardial apoptosis in rats (Ren et al. 2002). In 
contrast, when three weeks of administration of ethanol or water to rats was 
followed by an acute Langendorff experiment, infarct sizes were less and levels 
of apoptosis lower after ischemia-reperfusion in the hearts from the rats that 
had received ethanol than in the hearts from the controls. It would therefore 
appear that ethanol protects the heart from cellular injury under some circum-
stances, through adaptation to oxidative stress (Sato et al. 2002).
4.2. Other tissues
No evidence of cell death has been found in skeletal muscle exposed acutely or 
chronically to ethanol (Paice et al. 2003). Exposure to ethanol induces apopto-
sis in many other organs and various types of cell. For example, eight weeks of 
ethanol intake results in apoptosis in female and male rat livers. The effect is 
more evident in female than in male rats (Colantoni et al. 2003). In the devel-
oping rat forebrain, ethanol triggers widespread apoptotic neurodegeneration. 
The apoptotic response induced by ethanol cannot be predicted from the dose 
but rather depends on how rapidly a dose is administered, and on how long 
blood ethanol levels remain above a toxic threshold, in a range between 39 and 
43 mmol/l. Maintenance of blood ethanol concentrations at or above 43 mmol/
l for four consecutive hours is the minimum condition for triggering of neu-
rodegeneration (Ikonomidou et al. 2000). In neuroblastoma cells, ethanol con-
centrations of 34 mmol/l or greater specifi cally increase DNA fragmentation 
but necrosis occurs only at concentrations of 103 mmol/l or more (McAlhany 
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et al. 2000). Treatment of endothelial cells with concentrations of ethanol of < 
20 mmol/l activates a pathway promoting cell survival. Treatment with higher 
concentrations activates an apoptotic pathway (Liu et al. 2002). Chronic ad-
ministration of alcohol to rats suppresses apoptosis in the pancreas (Fortunato 
& Gates 2000).
5. ACETALDEHYDE AND APOPTOSIS 
5.1. Heart and other tissues
There are no reports of effects of acetaldehyde on cardiac apoptosis. With a rat as-
trocyte cell culture exposure to acetaldehyde for four days signifi cantly increases 
DNA fragmentation (Holownia et al. 1999). With hamster ovary cell cultures 
apoptosis is increased dose- and time-dependently by exposure to acetaldehyde 
(Zimmerman et al. 1995). Interestingly, facilitation of acetaldehyde metabolism 
by aldehyde dehydrogenase-2 transgene over-expression prevents acetaldehyde-
induced apoptosis in human endothelial cells (Li et al. 2004).
6. GENES ASSOCIATED WITH CARDIAC CELL ADAPTATION,   
 APOPTOSIS AND HYPERTROPHY
6.1. Atrial and brain natriuretic peptides 
6.1.1. General
Atrial and brain natriuretic peptides (ANP and BNP) are primarily produced 
by the heart. Both represent fi nal products of a precursor peptide. For exam-
ple, after processing of a pre-signal peptide, subsequent cleavage of proANP 
releases a mature ANP together with a prosegment called N-terminal ANP 
(NT-ANP). NT-ANP has a longer half-life than ANP, and measurement of 
NT-ANP gives a better indication of average ANP level over time than meas-
urement of ANP. Normally, the main site of secretion of BNP is the cardiac 
ventricle, that of ANP the atria (Ruskoaho 2003). 
Evidence suggests that both ventricular structure and neurohumoral fac-
tors are important in stimulating secretion of ANP and BNP. As would be 
expected, regulation of the biosynthesis and secretion of natriuretic pep-
tides involves complex mechanisms that control vasomotor tone, systemic 
blood pressure and electrolyte homeostasis. Myocardial stretching leads to 
release of ANP and BNP. Neurohormones such as endothelin-1, Ang II, cat-
echolamines, thyroid hormone and prostaglandins also stimulate natriuretic 
peptide gene expression and release (Yoshimura et al. 2001; Ruskoaho et al. 
2003). However, there are differences in expression of the genes. For exam-
ple, in a volume overloaded hypertrophy model ANP mRNA levels had al-
ready increased on day 1 and left ventricular mass on day 7. BNP mRNA 
19
levels remain unchanged throughout the study (Su et al. 1999). Under qui-
escent culture conditions p21 stimulates ANP expression but in cells cul-
tured under growth-activated conditions p21 suppresses ANP promoter ac-
tivity (Kovacic-Milivojevic et al. 1997).On the other hand, TNF-alpha is a 
strong stimulant of BNP secretion (Yoshimura et al. 2001). 
The natriuretic peptide system has emerged as one of the most important 
hormonal systems involved in the control of cardiovascular function. The phys-
iological effects of ANP and BNP include vasodilatation, natriuresis, and inhi-
bition of the renin-angiotensin-aldosterone and sympathetic nervous systems. 
ANP and BNP are also involved in neurotransmission, endocrine functions, 
and regulation of cell proliferation and hypertrophy (Filippatos et al. 2001; 
Ruskoaho  2003). 
Induction of the natriuretic peptide genes is a feature of cardiac hypertro-
phy in all mammalian species studied (Filippatos et al. 2001). ANP mRNA is 
found to correlate signifi cantly with the left-ventricular weight/body weight 
ratio, indicating that increased left ventricular ANP gene expression is related 
to cardiac hypertrophy. Similar results are found in relation to BNP (de Bold 
et al. 2001). However, hypertrophy and secretion of BNP do not always oc-
cur simultaneously. BNP is not necessarily secreted by cells in primary car-
diac hypertrophy but there is marked secretion of BNP with secondary car-
diac hypertrophy, for example that seen in aortic stenosis and hypertension 
(Yoshimura et al. 2001). Low ventricular ANP gene expression can be linked 
genetically to high cardiac mass, independently of blood pressure, and is con-
sistent with ANP playing a protective role against left ventricular hypertrophy 
(Masciotra et al. 1999). Results of experiments with transgenic mice in which 
the ANP gene has been deleted support this fi nding (John et al. 1995). In BNP 
knockout mice, ventricular BNP is undetectable but ventricular ANP concen-
trations are 37 times higher than in controls. Severe cardiac fi brosis occurs in 
the animals but no signs of hypertrophy are found, suggesting that BNP may 
serve primarily as an antifi brotic factor and that enhanced expression of ANP 
protects the animals from cardiac hypertrophy (Tamura et al. 2000). ANP has 
also antiproliferative effects in various other cells, including, for example, rat 
cardiac fi broblasts (Cao & Gardner 1995), and vascular smooth muscle cells 
(Itoh et al. 1990). ANP and BNP inhibit the cardiac hypertrophy and fi brosis 
induced by aldosterone via both the endocrine and autocrine-paracrine systems 
(Yoshimura et al. 2001). ANP also attenuates the growth-promoting effects of 
noradrenaline on myocardial cells (Calderone et al. 1998).
In both mice and rat cardiac myocytes, ANP induces apoptosis dose- and 
time-dependently, and cell-type-specifi cally (Wu et al. 1997; Kang et al. 2000). 
In copper-defi cient mice, metallothionein, a protein that protects against oxi-
dative injury, inhibits the transition from heart hypertrophy to failure by sup-
pressing apoptosis through inhibition of both cardiac ANP production and its 
apoptotic effect (Kang et al. 2000). Transgenic mice that over-express ANP 
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exhibit a 27% reduction in total heart weight and it was clear that the net 
effect of ANP on the myocardium in vivo is limitation of myocyte growth 
(Klinger et al. 1993). ANP and BNP dose dependently induce apoptosis of, for 
example, rat endothelial cells, with equal potencies, and treatment of endothe-
lial cells with ANP causes marked accumulation of p53 (Suenobu et al. 1999). 
However, the complexity of the system is highlighted by the fact that ANP 
also induces regeneration in human endothelial cells (Kook et al. 2003).
6.1.2. Natriuretic peptides and gender 
Treatment with 17-beta-estradiol leads to increased production of ANP in rat 
heart ventricles in a pressure-overload hypertrophy model. The fi ndings sug-
gest that the antihypertrophic effect of estradiol may be mediated by increased 
expression of ANP (van Eickels et al. 2001). However, no gender differences 
relating to ANP or BNP levels have been reported.
6.1.3. Natriuretic peptides and ethanol
In experiments in rats acutely administered ethanol, levels of left ventricular 
ANP mRNA and protein either remain constant (Wigle et al. 1995) or an 
increase in ANP tissue content is observed two hours after ethanol administra-
tion (Guillaume et al. 1994). Six weeks of ethanol ingestion by rats results in 
both ventricular ANP mRNA and protein levels being higher than in control 
rats (Wigle et al. 1993a) but administration of ethanol for two or four months 
has no effect (Kim et al. 2003). Administration of ethanol for eight months 
signifi cantly reduces ANP mRNA and protein levels in the ventricles of SHR 
but not of WKY rats (Guillaume et al. 1996a). In transgenic mice hearts in 
which there is over-expression of alcohol dehydrogenase and cardiac acetalde-
hyde levels are therefore four times higher than normal, ventricular ANP gene 
expression is several times higher than normal (Liang et al. 1999). 
In atrial tissue, in acute in vivo experiments involving treatment with eth-
anol, levels of ANP mRNA and protein remain constant (Wigle et al. 1993b) 
or ANP levels decrease (Guillaume et al. 1994). Moderate consumption of 
ethanol by rats for eight months increases atrial ANP levels, without altering 
ANP mRNA (Guillaume et al. 1996a). Consumption of alcohol for six weeks 
increases both atrial ANP mRNA and protein levels (Wigle et al. 1993a).
In plasma, the physiological response to acute administration of alcohol 
appears to depend on the volume of co-administered liquids. Plasma ANP 
levels correlate positively with atrial pressure in normal subjects (Sehested et 
al. 1998). The main mechanism involved in increased ANP release from atria 
after acute ethanol ingestion seems to be atrial stretching (Colantonio et al. 
1991). Several reports have been published on the effects of acute ethanol ad-
ministration on plasma ANP levels. Results have been confl icting (Colantonio 
et al. 1991; Hynynen et al. 1992; Leppäluoto et al. 1992; Ekman et al. 1994). 
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No alterations in plasma levels of ANP are evident after six weeks of ethanol 
treatment (Wigle et al. 1993a). After four or eight months of ethanol expo-
sure, plasma ANP levels are signifi cantly lower than in controls (Guillaume et 
al. 1996a; Kim et al. 2003).
In cardiac ventricular tissue, acute ingestion of ethanol reduces BNP 
mRNA levels to 38% of control levels (Wigle et al. 1995). In contrast, admin-
istration of ethanol for six weeks and two and four months results in no chang-
es in BNP gene expression (Wigle et al. 1993c; Kim et al. 2003). Consump-
tion of ethanol for eight months increased both ventricular BNP concentration 
and ventricular BNP mRNA in SHR (spontaneously hypertensive rat line) but 
not in normotensive WKY rats (Guillaume et al. 1996b). 
In the atrial tissue of rats to which ethanol has been administered acute-
ly, BNP mRNA levels are 43% of those in animals that have received water 
(Wigle et al. 1995). After chronic administration of ethanol to rats, elevated 
atrial BNP concentrations are observed without alterations in BNP mRNA 
levels (Guillaume et al. 1996b).
Circulating plasma BNP levels were high following six weeks of adminis-
tration of ethanol to rats (Wigle et al. 1993c). Four or eight months of mod-
erate ethanol consumption by rats resulted in circulating BNP levels below 
normal (Guillaume et al. 1996b; Kim et al. 2003).
6.2. p53
6.2.1. General
The protein p53 is a major element in a complex network that senses cellular 
stress, including DNA damage, hypoxia and hyperproliferation. Induction of 
apoptosis is the most conserved function of p53 but it also controls such cell 
functions as gene transcription, DNA synthesis, DNA repair, cell cycle arrest 
and aging. The activity of p53 is determined by stress type and individual 
cell/tissue characteristics. A stimulus that can result in elevation of p53 levels 
may not do so in all instances. In addition, when p53 levels are elevated, death 
does not always ensue. The mechanism by which the alternative fates of apop-
tosis or cell-cycle arrest occur remains, however, to be elucidated (Hofseth et 
al. 2004; Slee et al. 2004). 
Normal diploid cells have limited potential for replication. The number 
of times a cell can divide is determined by the lengths of the telomeres at the 
chromosome ends, which are shortened during each cell cycle by telomerase. 
Once a critical level of shortening has occurred, sensors for DNA damage are 
triggered and cell-cycle arrest or apoptosis is induced. p53 seems to be impor-
tant in relation to this response (for references see Igney & Krammer 2002). 
Interestingly, it has been discovered that chronic constitutive expression of p53 
accelerates aging in mice (Tyner et al. 2002). In the human heart, telomere 
shortening with increasing age could be a critical biological determinant of 
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heart failure in the elderly. Importantly, telomere loss leads to cardiac dilata-
tion and heart failure associated with up-regulation of p53 (Leri et al. 2003). 
The pro-apoptotic potential of p53 has been demonstrated in numerous 
systems, including the response of cardiac myocytes to stress. For example, in-
duction of p53 down-regulates bcl-2 and up-regulates bax in myocytes, thus 
decreasing the bcl-2:bax ratio and increasing the susceptibility of cells to un-
dergo apoptosis (Leri et al. 1998a; Leri et al. 1998b). Inhibition of functioning 
of p53 prevents activation of the renin-angiotensin system and stretch-medi-
ated apoptosis in ventricular myocytes (Leri et al. 2000b). However, in some 
studies p53 levels do not increase with mechanical stretching, pressure over-
load or cardiac hypertrophy (Kim et al. 1994; Fortuno et al. 1999). Prolonged 
hypoxia relating to neonatal cardiomyocytes results in substantial induction 
of expression of p53 and apoptosis (Long et al. 1997). Ischemic precondition-
ing, in an ischemia-reperfusion model involving isolated working rat hearts 
(Maulik et al. 2000), and hypothermia (Ning et al. 2002) prevent p53 activa-
tion and inhibit apoptosis. In contrast, myocyte apoptosis occurs as readily in 
the hearts of mice nullizygous for p53 as in wild-type littermates subjected to 
myocardial infarction or ischemia-reperfusion (Bialik et al. 1997; Webster et 
al. 1999). Results of numerous other studies also support both p53-depend-
ent and -independent apoptotic pathways in the heart. In severe congestive 
heart failure expression of p53 and apoptosis are signifi cantly increased in hu-
man cardiomyocytes (Song et al. 1999). In animal studies, for example pacing-
induced heart failure in dogs enhances apoptosis, hypertrophy and expression 
of p53 and p53-dependent genes in ventricular myocytes (Leri et al. 1998b). 
These results suggest that p53 may play an important pathophysiological role 
in relation to heart failure.
6.2.2. p53 and gender
It has been reported that estradiol induces functional inactivation of p53 in 
breast cancer cells (Molinari et al. 2000). On the other hand, p53 infl uences 
the effects of estrogens, as it binds to multiple domains of the human estro-
gen receptor and down-regulates expression of some estrogen-responsive genes 
such as bcl-2 (Liu et al. 1999). Cardiac fi broblasts are cell targets for estrogens. 
However, in both sexes, p53 protein levels are similar in cardiac fi broblasts 
(Zhao et al. 2002) and p53 mRNA levels are similar in skeletal hind limb 
muscle (Nakahara et al. 2003). In contrast, gender infl uences expression of 
p53 in MRL/lpr mice (autoimmune mouse model of Sjögren’s syndrome). The 
amount of p53 mRNA is higher in lacrimal and submandibular tissues of fe-
male mice than in lacrimal and submandibular tissues of male mice (Toda et 
al. 1998).
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6.2.3. p53 and ethanol
No reports on the effects of ethanol on cardiac levels of p53 have been pub-
lished. In rat skeletal hind limb muscle, p53 mRNA levels are not affected 
by in vivo exposure to ethanol, acutely (2.5 hours) or chronically (six to seven 
weeks), even with cyanamide (a dehydrogenase inhibitor) predosing (Naka-
hara et al. 2003). In regenerating rat liver, p53 transcript levels are increased 
(Lumpkin et al. 1995) or unchanged (Zhang et al. 2000b) following acute eth-
anol exposure. In normal mice, exposure to ethanol for three weeks induces a 
signifi cant increase in the number of apoptotic hepatocytes. Apoptosis is com-
pletely abrogated in p53-defi cient mice suggesting that p53 is necessary for 
ethanol-induced apoptosis, at least in the liver (Pani et al. 2004). Exposure to 
ethanol induces apoptosis and up-regulates expression of p53 also, for example, 
in neuronal cells (de la Monte et al. 2000). However, in human rectal mucosal 
cells, chronic alcohol abuse led to cell hyperproliferation with no change in 
p53 immunostaining (Simanowski et al. 2001). Acute exposure of human epi-
thelial cells to non-cytotoxic ethanol concentrations does not affect p53 pro-
tein levels (Guo et al. 1997).
6.3. p21
6.3.1. General
It has been suggested that p21 is involved in numerous important cell process-
es, including DNA repair, differentiation and apoptosis (Gorospe et al. 1997). 
It is a p53 target gene. Expression of p21 has been shown to be up-regulated 
by p53 in response to the presence of DNA-damaging agents (El-Deiry et al. 
1993). When DNA damage is limited and reparable, p53 activates genes, in-
cluding p21, which relate to cell-cycle arrest and DNA repair. When DNA 
damage is very severe, p53 activates genes inducing apoptosis (Nakamura 
2004). Apoptosis that is p53-dependent occurs normally in cells lacking p21. 
On the other hand, many reported pathways for induction of p21 expression 
are totally independent of p53 (Cox 1997). In various systems in which expo-
sure to stressful stimuli results in p53-independent cell death, p21 has been 
found to be involved in survival responses. Adenovirus-driven ectopic expres-
sion of p21 results in substantial protection against p53-induced apoptosis, in-
dicating that p21 rescues cells from a path to programmed cell death (Gorospe 
et al. 1997). However, cell-fusion experiments have shown that apoptosis pre-
dominates over cell-cycle arrest, irrespective of p21 levels and cell-cycle status 
(for references see Cox 1997). Introduction of exogenous p53 overcomes p21-
mediated cell-cycle arrest at G1 and induces apoptosis, although p21 expres-
sion is unaffected (Kagawa et al. 1997). 
For example, mechanical loading, addition of Ang II and hypoxia rapidly ac-
tivate p21 in cultured neonatal rat cardiac myocytes (Sadoshima & Izumo 1993; 
Sadoshima & Izumo 1996; Seko et al. 1996). p21 is also involved in the signal 
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transduction of a variety of hormones and growth factors (Kovacic-Milivojevic et 
al. 1997). Anti-p21 antibody completely blocks DNA synthesis and cell prolif-
eration in response to Ang II, endothelin-1 and some other hormones (Schieffer 
et al. 1997). The p21 protein has also been reported to inhibit DNA replication 
and block cell-cycle progression (Ogawa et al. 1997). The importance of p21 as 
a regulator of senescence has been clearly established (Serrano & Blasco 2001). 
p21 stimulates rat ANP gene transcriptional activity in a cultured neonatal rat 
ventriculocyte model (Thorburn et al. 1993) and the p21-sensitive element is 
located within the ANP gene transcription start site. Under quiescent culture 
conditions, p21 stimulates ANP promoter activity, but in cells cultured under 
growth-activated (e.g., endothelin-1) conditions, p21 suppresses promoter activ-
ity (Kovacic-Milivojevic et al. 1997).
Cardiomyocytes are terminally differentiated cells. Over 95% of adult car-
diomyocytes are known to exist in the G0/G1 phase of the cell cycle (for refer-
ences see McGill & Brooks 1995). p21 regulates the cell cycle by inhibiting 
the cyclin-dependent kinases required for progression from the G1 to the S 
phase (El-Deiry et al. 1993). In response to DNA damage, cells arrest cell cycle 
progression in a co-ordinated way, and induce expression of gene products that 
facilitate DNA repair (Deng et al. 1995). p21 is therefore normally an im-
portant component of the checkpoint for cell DNA damage (Cox 1997). Mice 
null for the p21 gene develop normally but are defi cient in G1 cell-cycle arrest 
in response to DNA damage, and thus, defective in relation to DNA repair. 
However, the apoptotic response in such mice is unaltered (Deng et al. 1995; 
Brown et al. 1997).
Activated p21 has been linked to cardiac hypertrophy by a number of inves-
tigators (Kovacic-Milivojevic et al. 1997). A p21-dependent pathway mediates 
hypertrophy, at least in part, following stimulation of a classical G-protein-cou-
pled receptor in neonatal rat cardiac myocytes (Thorburn et al. 1993). Phenyle-
phrine, Ang II and other hypertrophic agonists as well as mechanical loading 
cause biochemical activation of p21, and the p21-mediated pathway is suffi cient 
to induce growth or differentiation of mammalian cells (Sadoshima & Izumo 
1993; Thorburn et al. 1995). Transgenic mice that over-express cardiac p21 ex-
hibit morphological, physiological, and genetic markers, including elevated ANP 
gene expression of myocardial hypertrophy (Hunter et al. 1995). On the other 
hand, p21 is able to inhibit proliferating cell nuclear-antigen-mediated hypertro-
phy in adult cardiomyocytes (Engel et al 2003). mRNA and protein expression of 
p21 are down-regulated signifi cantly but transiently during development of pres-
sure-overload-induced LV hypertrophy in the rat. It has therefore been suggested 
that adjustment to intracellular balances between levels of positive and negative 
regulators of the cell cycle in cardiomyocytes is required to allow compensatory 
growth to occur during development of LV hypertrophy (Li & Brooks 1997). In 
contrast, in dogs with heart failure, hypertrophy is accompanied by p21 protein 
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up-regulation, and both hypertrophy and p21 levels decline after successful treat-
ment, (Sabbah et al. 2003). In human idiopathic dilated cardiomyopathic hearts 
that have progressed to heart failure, p21 expression is decreased (Steenbergen et 
al. 2003). 
The precise role of p21 in relation to apoptosis in myocytes is still not clear. 
p21 mRNA levels are increased in failing and non-failing hearts of SHR, and 
an elevated number of apoptotic cells accompanies the p21 mRNA increase 
(Li et al. 1997). In cultured neonatal rat cardiac myocytes exposure to hypoxia 
results in apoptosis and is accompanied by increased p53 and p21 levels (Long 
et al. 1997) or decreased p21 protein accumulation (Adachi et al. 2001). In a 
study by Hauck et al. (2002), down-regulation of p21 is required for hypoxia-
induced cardiomyocyte apoptosis, and ectopic p21 expression is able to inhibit 
apoptotic cell death.
6.3.2. p21 and gender 
The p21 exon includes an estrogen-responsive element (Pethe & Shekhar 
1999). However, no gender-dependent differences in p21 levels have been 
reported.
6.3.3. p21 and ethanol
There are no reports relating to effects of ethanol or acetaldehyde on p21 ex-
pression in the heart. In the liver, ethanol promotes accumulation of p21, and 
this may be an adaptive response that helps livers that have been exposed to 
ethanol to survive stress situations (Koteish et al. 2002). In another study, eth-
anol treatment resulted in no change in p21 mRNA expression (Zhang et al. 
2000b). In human epithelial cells (Guo et al. 1997) and rat aortic smooth mus-
cle cells (Sayeed et al. 2002) exposure to ethanol results in p21 expression and 
inhibited cell proliferation.
6.4. Bcl-2 and bax 
6.4.1. General
The B cell lymphoma gene-2 (bcl-2) family has over 20 members, and can be 
divided into anti-apoptotic (e.g. bcl-2) and pro-apoptotic proteins (e.g. bax) (Ig-
ney & Krammer 2002). The chief function of bcl-2 family proteins is to regulate 
release of cytochrome c, apoptosis-inducing factor and other proteins from mi-
tochondria, with pro-apoptotic bcl-2 family proteins promoting, and anti-apop-
totic bcl-2 family members suppressing protein release by affecting the perme-
ability of mitochondrial membranes. The relative ratios of anti- and pro-apop-
totic bcl-2 family proteins dictate the sensitivities of cells to various apoptotic 
stimuli, including hypoxia, presence of oxidants and Ca2+ overload (Reed 2002). 
Although bax and bcl-2 heterodimerize and inhibit each other, both proteins can 
act independently in regulating apoptosis (Regula et al. 2003). 
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Hearts from rats subject to chronic hypoxia exhibit an increased rate of 
apoptosis and a decrease in bcl-2 protein level. In contrast, exposure of isolated 
neonatal rat cardiac myocytes to hypoxia also results in signifi cantly increased 
apoptosis but bcl-2 levels remain unchanged (Jung et al. 2001; Riva et al. 
2001). Ischemia-reperfusion results in cardiomyocyte apoptosis in concert with 
down-regulation of bcl-2 mRNA (Cheng et al. 1996). In some studies, precon-
ditioning results in up-regulation of the bcl-2 gene, and bcl-2 expression cor-
relates with reduction of cardiomyocyte apoptosis and infarct size (Maulik et 
al. 1999; Xie et al. 2001). In transgenic mice, over-expression of bcl-2 reduces 
infarct size and renders the heart more resistant to apoptosis (Chen et al. 2001). 
As in other cells, therefore, over-expression of bcl-2 protects cardiac myocytes 
from apoptosis (Kirshenbaum & de Moissac 1997). Antisense bcl-2 oligode-
oxynucleotides completely abolish the cardioprotective effects of adaptation by 
eliminating the “antideath signal” of bcl-2 (Hattori et al. 2001). 
In LV hypertrophy and LV dysfunction bcl-2 levels are lower and apoptosis 
increased compared to controls (Condorelli et al. 1999). In man, heart failure is 
characterized by an increase in myocyte apoptosis, despite enhanced expression 
of bcl-2 (Olivetti et al. 1997; Latif et al. 2000). Enhanced expression of bcl-2 
in the failing heart suggests that compensatory mechanisms are activated in 
the overloaded myocardium in an attempt to maintain cell survival (Olivetti 
et al. 1997). In apoptosis resulting from the presence of reactive oxygen spe-
cies bcl-2 levels in myocytes decrease (Cook et al. 1999; Suzuki et al. 2001) or 
remain unchanged (von Harsdorf et al. 1999). 
The bax gene promoter contains four p53-binding sites that can be spe-
cifi cally activated by p53 (Miyashita & Reed 1995). For example, myocardial 
stretching (Leri et al. 1998a) and chronic hypoxia (Jung et al. 2001) induce 
expression of bax and myocyte apoptosis. Ischemic preconditioning induces 
down-regulation of bax, and cardioprotection, as evidenced by reduced num-
bers of apoptotic cardiomyocytes (Nakamura et al. 2000; Hattori et al. 2001). 
In homozygotic knockout mice lacking the bax gene the heart is more protect-
ed against myocardial ischemia-reperfusion injury than in normal wild-type 
mice (Hochhauser et al. 2003).
Marked up-regulation of bax and cardiomyocyte apoptosis contribute to the 
transition from LV hypertrophy to LV dysfunction in response to chronic pres-
sure in rats (Condorelli et al. 1999). In groups with dilated cardiomyopathy 
and ischemic heart disease there are signifi cant increases in levels of bax and 
apoptosis (Anversa et al. 1998; Latif et al. 2000). Pacing-induced heart failure 
in dogs results in signifi cant increases in apoptosis and expression of bax (Leri 
et al. 1998b). In a study of myocytes from the hearts of patients with conges-
tive heart failure, the level of bax is no different from normal (Olivetti et al. 
1997). Bax is also up-regulated, for example, during Ang II-induced cardiac 
myocyte apoptosis (Diep et al. 2002).
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Apoptosis is increased and the bcl-2/bax ratio decreased in infarcted areas 
of human hearts (Baldi et al. 2002). In rats, a reduction in the bcl-2/bax pro-
tein ratio and an increase in apoptosis occurs, for example, in LV hypertrophy 
and LV dysfunction (Condorelli et al. 1999) and after exposure to oxidative 
stress (Suzuki et al. 2001). 
6.4.2. Bcl-2, bax and gender
Bcl-2 is an estrogen-responsive gene (Dubal et al. 1999). Basal protein levels 
of bcl-2 are higher in cardiac fi broblasts from female rats than in cardiac fi -
broblasts from male rats (Zhao et al. 2002). However, in rat skeletal hind limb 
muscle bcl-2 levels are similar in both sexes (Nakahara et al. 2003). Toda et 
al. (1998) reported that the amount of bcl-2 mRNA is higher in the lacrimal 
glands of female autoimmune mice than in the lacrimal glands of male au-
toimmune mice. No reports on the effects of gender on bax gene expression 
have been published, although testosterone has been shown to induce bax and 
decrease bcl-2 protein levels and promote apoptosis in human renal tubular 
cells (Verzola et al. 2004).
6.4.3. Bcl-2, bax and ethanol
In primary cardiomyocyte cultures, exposure to ethanol decreases cell viabil-
ity in a dose-dependent manner, and the content of bax protein increases 
(Chen et a. 2000).
In rat skeletal hind limb muscle, bcl-2 mRNA levels are unaffected by 
acute (2.5 hours) or chronic (six to seven weeks) exposure to ethanol in vivo, 
even after cyanamide (an inhibitor of dehydrogenase) predosing (Nakahara et 
al. 2003). Hepatic expression of bcl-2 and bax proteins is markedly higher 
than normal in patients with alcoholic liver disease and in mice to which etha-
nol has been administered chronically (Rashid et al. 1999; Hong et al. 2002). 
In rats, bax mediates acute ethanol-induced hepatocytes apoptosis Adachi et 
al. 2004). However, chronic administration of alcohol induces apoptosis in the 
livers but does not affect bax or bcl-2 mRNA levels. Incubation of HepG2 
cell line cells with ethanol in the absence of bcl-2 results in apoptosis. On the 
contrary, exposure to ethanol causes no apoptosis in cells over-expressing bcl-
2 (Wu & Cederbaum 1999). There are numerous studies on the roles played 
by bcl-2 and bax in regulating ethanol-induced apoptosis in, for example, the 
CNS (Moore et al. 1999; de la Monte et al. 2000; Mooney & Miller 2001). 
6.5. Tumor necrosis factor-alpha
6.5.1. General
TNF-alpha is a major mediator of apoptosis, infl ammation and immunity. 
It signals via two cell-surface receptors, TNF-R1 and TNF-R2. Binding of 
TNF-alpha to TNF-R1 triggers a series of intracellular events that result in 
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activation of two major transcription factors, nuclear factor-kB (NF-kB) and 
c-jun. These transcription factors are responsible for the inducible expression 
of genes important in relation to various biological processes, including cell 
growth and death, development, oncogenesis, and immune, infl ammatory and 
stress responses (Chen & Goeddel 2002). For example, myocardial stretching is 
followed by TNF-alpha production in the heart (Kapadia et al. 1997).
TNF-alpha activates extracellular matrix remodelling, and appears to con-
trol both tissue destruction and rebuilding (Feldman et al. 2000). TNF-alpha 
depresses myocardial contractile function. In addition to calcium dyshomeos-
tasis, mechanisms by which TNF-alpha causes myocardial dysfunction include, 
for example, oxidative stress, myocyte apoptosis and induction of other cardiac 
depressants such as IL-6 (Meldrum 1998). Accumulating evidence indicates 
that myocardial TNF-alpha is an autocrine contributor to myocardial dys-
function and cardiomyocyte hypertrophy and death in, for example, ischemia-
reperfusion injury, sepsis, heart failure, viral myocarditis, acute myocardial in-
farction and cardiac allograft rejection (Meldrum 1998; Feldman et al. 2000). 
Transgenic mice with cardiac-restricted TNF-alpha over-expression develop 
cardiac failure and die prematurely (Kubota et al. 1997; Bryant et al. 1998). 
Over-expression of TNF-alpha activates both anti- and pro-apoptotic path-
ways in the myocardium of transgenic mice. Most of the cells suffering apop-
tosis appeared not to be myocytes, even in mice with overt congestive heart 
failure. It would seem that TNF-alpha alone is not suffi cient to induce apopto-
sis in cardiac myocytes in vivo (Kubota et al. 2001). In contrast, in a primary 
culture of rat cardiac myocytes, a dose-dependent increase in caspase-3 activity, 
indicative of apoptosis, is observed when cells are incubated with increasing 
concentrations of TNF-alpha (Carlson et al. 2002). Chronic infusion of TNF-
alpha in vivo results in rapid development of dilated cardiomyopathy associ-
ated with increased myocyte apoptosis (MacLellan & Schneider 1997). Adeno-
viral-mediated gene transfer of bcl-2 prevents apoptosis of neonatal ventricular 
myocytes induced by TNF-alpha (deMoissac et al. 1998). In patients with con-
gestive heart failure, TNF-alpha levels do not correlate with degree of cell loss 
(Rayment et al. 1999). Interestingly, soluble TNF type-2 receptor plasma lev-
els identify a heart failure-patient subgroup with high levels of cardiomyocyte 
apoptosis (Saraste et al. 2002).
Emerging evidence suggests that TNF-alpha predominantly triggers apop-
tosis in cells either defi cient in or defective in relation to NF-kB activation. In 
ventricular myocytes TNF-alpha is likely to activate dual signalling cascades, 
with one pathway leading to apoptosis and the other pathway, mediated via 
NF-kB, dominating to suppress pro-death signals and apoptosis (Mustapha et 
al. 2000; Bergmann et al. 2001). TNF-alpha protects the heart, for example, 
against ischemia-induced apoptosis (Kurrelmeyer et al. 2000). Pretreatment of 
rats with TNF-alpha has been shown to protect the heart from ischemia reper-
fusion injury (Eddy et al. 1992). 
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6.5.2. TNF-alpha and gender
In humans, there are increased percentage TNF-alpha producing monocytes 
found in men as compared with women (Bouman et al. 2004). In transgen-
ic mice that over-express cardiac-specifi c TNF-alpha, left ventricular func-
tion and the six-month survival rate are signifi cantly better in females than in 
males, though TNF-alpha levels are identical in females and males (Kadokami 
et al. 2000). In rat liver, basal TNF-alpha protein levels are found to be similar 
in both sexes (Colantoni et al. 2003). In contrast, in the lacrimal glands of fe-
male autoimmune mice amounts of TNF-alpha mRNA are higher than in the 
lacrimal glands of male autoimmune mice (Rocha et al. 1998). 
6.5.3. TNF-alpha and ethanol
There are no reports on the effects of ethanol or acetaldehyde on TNF-alpha 
gene expression in the heart. In the liver, TNF-alpha is required for nor-
mal hepatic regeneration, and in relation to repair of ethanol-related damage 
(Diehl 1999). Exposure to ethanol or acetaldehyde for 24 to72 hours results 
in expression of TNF-alpha in HepG2 hepatocytes (Gutierrez-Ruiz et al. 
1999). Exposure of rats to ethanol for two weeks iv vivo does not result in 
up-regulation of basal hepatic gene expression of TNF-alpha (Järveläinen et 
al. 1999; Fleming et al. 2001) but eight weeks of exposure of rats to ethanol 
increases TNF-alpha protein levels and apoptosis. These effects of ethanol 
are more evident in female than in male livers, probably contributing to the 
greater sensitivity of female livers to ethanol-induced injury (Colantoni et al. 
2003). The effects of chronic exposure to acetaldehyde are the opposite. Four 
weeks of treatment with ethanol and aldehyde dehydrogenase inhibitor re-
sults in sustained increases in blood and liver acetaldehyde levels and down-
regulates TNF-alpha gene expression in rats (Lindros et al. 1999). There are 
numerous other reports on the effects of ethanol on TNF-alpha mRNA and 
protein levels. For example, in cultured epidermoid skin cells, low concen-
trations (40 to 100 mmol/l) of ethanol induce apoptosis by enhancing the 
effects of TNF-alpha (Neuman et al. 2002). Ethanol-induced subchronic 
gastritis results in activation of TNF-alpha expression followed by apoptosis 
in the gastric mucosa (Liu & Cho 2000). 
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AIMS OF THE STUDY 
It has been suggested that excessive ethanol consumption is responsible for a 
number of deleterious effects on heart muscle, including the serious condition 
known as dilated cardiomyopathy. Mechanisms underlying ethanol-induced 
cardiac muscle damage are, however, largely unknown.
The aims of the study were:
1. To investigate whether ethanol is capable of triggering cardiac adaptation 
processes and changing the expression of the genes which regulate apopto-
sis and hypertrophy. 
2. To develop and employ a quantitative RT-PCR method for determining 
mRNAs of specifi c proteins in muscle samples.
3. To assess possible effects of short-term exposure to ethanol and acetalde-
hyde derived from ethanol on apoptosis and genes associated with cardiac 
adaptation in vivo.
4. To evaluate acute effects of exposure to ethanol and acetaldehyde on apop-
tosis and genes associated with cardiac cell adaptation in the isolated per-
fused rat heart.
5. To explore the effects of chronic ethanol consumption on cardiac apoptosis 




1. ANIMALS AND EXPERIMENTAL DESIGN
1.1. One-week immobilization and skeletal muscle: a methodological  
 study (I)
Male Wistar rats (Laboratory Animal Center, University of Helsinki) were 
housed in light and temperature controlled rooms with a 12 h light: 12 h 
dark cycle. Animals had free access to chow and tap water. At the age of 11 
weeks animals were randomly assigned to control (n=6) and immobilization 
(n=6) groups. Immobilization for one week was performed by bilateral hind 
limb casting under anaesthesia (Booth & Kelso 1973). The ankles were fi xed 
in maximal plantar fl exion and the plaster cast extended around the knee and 
hip joints, which were immobilized at approximated resting angles. Strips of 
plaster of paris connected both hind limb casts dorsally, cranial to the tail to 
prevent the legs from slipping out of the cast. At the end of the experiment, 
gastrocnemius, plantaris and soleus were rapidly excised and frozen in liquid 
nitrogen. Muscle samples were stored in –80°C until mRNA analysis.
1.2. Short-term experiment in vivo (II,IV)
96 2-month-old male Wistar rats (Laboratory Animal Center, University of 
Helsinki) were randomly assigned to 12 experimental groups. Animals were 
housed in a temperature-controlled room with a 12 h light: 12 h dark cycle 
and provided with chow and water ad libitum. The four main experimental 
groups were as follows: controls (C: half of the group saline 8.3 ml/kg i.p. once 
a day; half of the group no treatment); ethanol (E: 1g/kg body weight i.p. as 
a 12% w/v solution in saline once a day); calcium carbimide (CC: half of the 
group calcium carbimide 100 mg/kg of diet; half of the group calcium carbim-
ide 100 mg/ kg of diet + saline i.p.) and ethanol + calcium carbimide (E+CC: 
ethanol 1g/kg body weight i.p. once a day + calcium carbimide 100 mg/kg of 
diet). Each of these four experimental groups was divided into three subgroups 
based on duration of treatment, i.e. 2,5, or 8 days. The calcium carbimide diet 
started in the morning on day 1, ethanol on day 2. This way, in the 2-day ex-
periment rats received calcium carbimide for 2 days and ethanol for 1 day, in 
the 5-day experiment rats received calcium carbimide for 5 days and ethanol 
for 4 days, and in the 8-day experiment for 8 days and 7 days, respectively. 
Blood samples for ethanol and acetaldehyde measurements were taken from 
the tail vein 2 hours after alcohol injection 1 day before decapitation and for 
N-terminal ANP at the time of decapitation. After decapitation, hearts were 
removed within 60 seconds, weighed and the free walls of the left ventricles 
were carefully dissected and frozen in liquid nitrogen for later RNA isolation. 
All samples were stored in –80°C until mRNA and ELISA analysis.
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1.3. Acute experiment with isolated heart (III)
Male Wistar rats weighing from 260 to 410 g (Laboratory Animal Center, 
University of Helsinki) were maintained on rat chow and water ad libitum in a 
room with a lighting sequence of 12 h light and 12 h dark. The rats were anti-
coagulated with heparin (500 IU/kg body weight i.p.) and killed by decapita-
tion 20 min later in CO2 anaesthesia. The thoracic cavity was quickly opened 
and the heart was cooled with ice-cold perfusion fl uid. The aorta was cannu-
lated superior to the aortic valve and retrograde perfusion was started with 
perfusion fl uid [DMEM with 25 mM HEPES (Gibco), supplemented with 
2.5 mM L-carnitine, 5 mM creatine, 5 mM taurine, 2 mM sodium pyryvate 
(Sigma), 20 IU/l Insulin Actrapid (Novo Nordisk), pH 7.4] equilibrated with 
95% O2 / 5% CO2 at 37°C. The hearts were perfused with a peristaltic pump 
(Perista AC 2110) at a fl ow rate of 7 ml/min and stimulated at 300 beats/min 
by Grass stimulator (Grass S88 stimulator, 5V, 0.5 ms). After the equilibration 
period (30 min) the hearts were perfused for 150 min in the absence (n=8) or 
presence of 500 µM acetaldehyde (n=9), or 5% (vol/vol) ethanol (n=7). After 
the perfusion period, the hearts were removed within 60 seconds and the free 
walls of the left ventricles were carefully dissected and immediately frozen in 
liquid nitrogen. All tissue samples were stored at –80°C until mRNA and 
ELISA analysis.
1.4. Chronic experiment in vivo (V)
Alcohol avoiding ANA (ALKO Non Alcohol) rats (F65) of both sexes were 
used. The rats were housed in groups of four to fi ve animals under a 12h/12h 
light/dark cycle. The animals received standard food ad libitum in pellet form 
during the forced exposure and in powder form during the self-selection peri-
ods. The ethanol-exposed rats (females n=6; males n=8) were given 12% (v/v) 
ethanol as the only available fl uid from the age of 3 months to 24 months of 
age, except for the self selection period (3 weeks) at the beginning and at the 
end of the exposure, when rats were allowed a free choice between 10% etha-
nol and tap water, to measure their individual voluntary ethanol consumption. 
The control rats (females n=7; males n=5) had only water available. The con-
sumption of ethanol was carefully monitored monthly for a period of one week 
during the whole ethanol exposure period. During the forced ethanol period 
the ethanol consumption of the ANA males increased from 3.83 ± 0.26 g/kg 
to 4.99 ± 0.30 g/kg per day and of the ANA females from 6.16 ± 0.35 to 7.14 
± 0.28. A week before killing the rats, the ethanol-exposed rats were with-
drawn from ethanol and had only food and water available for the last week of 
the experiment. Prior to decapitation, the rats were anaesthetized with sodium 
pentobarbital (60-120 mg/kg) intraperitoneally. After decapitation hearts were 
removed within 60 seconds, weighed and free walls of left ventricles were im-
mediately frozen in liquid nitrogen for later RNA isolation. All tissue samples 
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were stored at –80°C until mRNA and apoptosis ELISA analysis were per-
formed. The animal model and the protocol for ethanol administration have 
been previously described in detail (Rintala et al. 1997). 
1.5. Ethical considerations
The animal studies were conducted in accordance with the principles of the 
Declaration of Helsinki and approved by the National Public Health Institu-
tion Animal Care and Use Committee (II, IV, V) or by the Committee for ani-
mal Care and Use of the Wihuri Research Institute (III).
2. BLOOD AND TISSUE SAMPLING
2.1. Measurement of blood ethanol and acetaldehyde levels
Blood samples were collected into tubes containing 22.5 mg of sodium fl uo-
ride and 22.5 mg of potassium oxalate as anticoagulants for a volume of 10 ml 
of blood. Chilled tail blood samples were hemolyzed, and their ethanol and 
acetaldehyde contents measured with headspace gas chromatography (Perkin-
Elmer F40). The conditions for analysis were as reported earlier (Eriksson et al. 
1977). In short, the ethanol samples were diluted 1:10 in ice-cold water and 
all samples were stored in vials. Sealed vials were heated to 65°C and the con-
ditions for analysis were the following: column 15% polyethylene glycol on 
Celite 60/100; oven temperature 75°C; transfer line and detector temperature 
170°C; carrier gas fl ow rate (N2) 20 ml/min.
2.2. Measurement of blood N-terminal ANP levels 
Blood for assay was taken in tubes containing aprotinin (500 IU/ml) and 
EDTA (1mg/ml) and immediately placed on ice. After centrifugation at 1000g 
for 10 min at 4°C, aliquots of plasma were stored at -80°C and later subjected 
to radioimmunoassay (RIA) by a commercial kit (Biotop, Oulu, Finland). All 
the samples of an experiment were run within the same assay. 
2.3. Analysis of mRNA levels by quantitative RT-PCR method
Total RNA was extracted from frozen muscle samples by using a modifi cation 
of the acid guanidium thiocyanate-phenol-chloroform extraction (RNAzol B, 
Tel-Test, Friendswood, TX, USA). Frozen muscles were weighed and homoge-
nised with Polytron (Kinematika, Littau, Switzerland) and RNA isolation was 
performed according to the manufactures recommendations except that the 
actual RNA extraction phase was performed twice to eliminate all genomic 
DNA contamination. This way, amplifi cation of non-reverse transcribed RNA 
produced no detectable signal. The total RNA concentration was assessed spec-
trophotometrically (Gene Quant, Pharmacia Biotech, Finland).
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One µg of total sample RNA was reverse transcribed to cDNA with both 
oligo-dT (Pharmacia Biotech) and random hexamer primers using Superscript 
II enzyme (Life Technologies). To evaluate the effi ciency of the reverse tran-
scription reaction, i.e. the amount of cDNA synthesized, a known amount of 
control RNA was added to each reaction tube as an internal standard.
Control RNA was produced by in vitro transcription by fi rst construct-
ing synthetic DNA templates that contained two primer pairs complementary 
to those used to amplify cDNAs of interest. DNA templates also contained 
sequences for the bacteriophage T7 promoter at the 5’ end for transcription 
into RNA and a poly A tail at the 3’ end to facilitate RT by oligo-dT. Con-
trol RNA product was separated from synthetic DNA templates after in vitro 
transcription using phenol/chloroform extraction and ethanol precipitation af-
ter incubation with RNAse-free DNAse (Promega, Madison, Wisconsin, USA) 
(Feldman et al. 1991). Control RNAs were tested for DNA contamination by 
performing RT-PCR in the absence of reverse transcriptase enzyme.
The concentration of the control cDNA can adversely affect the amplifi ca-
tion effi ciency of the sample DNA, thus the optimal amount of control RNA 
for each gene was defi ned by including varying amounts of control RNA for 
each RT-PCR reaction. This was to ensure that the range of concentrations for 
both the sample cDNA and the control DNA allows amplifi cation within the 
exponential range.
The cDNA was amplifi ed in a DNA Thermal Cycler (Perkin Elmer) as de-
scribed in detail in study III. A trace amount of γ32P-labeled 3’ primer was 
added to provide about 1.5x106 cpm per reaction to label the DNA. In this 
way, each synthesized DNA strand was radiolabeled and PCR primers ampli-
fi ed both sample and control cDNA, as they both included sequences comple-
mentary to the primer. 
In using quantitative PCR, it is mandatory that colinear amplifi cation 
is obtained with the control cDNA and the sample. To ensure this and that 
measurements were performed during the exponential phase of amplifi cation, 
10 µl of each PCR reaction mixture was removed every fourth cycle during cy-
cles 12 to 32. PCR product aliquots were electrophoresed on 4.25% (w/v) Nu-
SieveGTG gel (FMC Bioproducts). The amplifi cation products of the control 
cDNA and the cDNA of the sample were different in size, and therefore could 
be separated electrophoretically. Gels were stained with ethidium bromide and 
amplifi cation products were visualized by UV light. Bands representing the 
gene and the control were excised from the gel separately and the radioactiv-
ity of each band was determined by Cerencov counting. The values from the 
cellular and control bands were plotted on a semi-logarithmic scale against the 
number of amplifi cation cycles. Parallel curves indicate that despite a differ-
ence in size, the two templates were amplifi ed with comparable amplifi cation 
effi ciencies. Comparing the levels of radioactivity, the mRNA level of interest 
could then be calculated from the known amount of control RNA by using 
values from the exponential cycles (Feldman et al. 1991).
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2.4. Quantifi cation of cytosolic DNA fragmentation by sandwich   
 enzyme immunoassay
For quantifi cation of DNA fragmentation, specifi c determination of cytosolic 
mononucleosomes and oligonucleosomes was performed using a commercial 
quantitative sandwich ELISA kit (Boehringer Mannheim). In this procedure 
10 mg of frozen heart left ventricular free wall tissue was homogenized at room 
temperature using a glass homogenizer in 200 µl of the lysis buffer supplied 
with the kit. After incubation for 30 min at room temperature the homoge-
nate was centrifuged at 200 g for 10 min. The activity of the supernatant was 
measured immediately; all samples of an experiment in one assay, for mono- 
and oligonucleosomes according to the manufacturer’s recommendations.
3. STATISTICAL ANALYSIS
All data are presented as mean ± standard error of mean (S.E.M.). In studies 
I-IV the data were analyzed by the non-parametric Mann-Whitney U test us-
ing the StatView 4.5 statistical package (Abacus Concepts, Ca, USA). In study 
V comparisons between groups were done with two-way analysis of variance 
(ANOVA) and correlation analysis was done with Pearson’s correlation coef-
fi cients using SPSS for Windows 12.0 (SPSS Inc., Chicago, IL, USA). p<0.05 
was considered statistically signifi cant.
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RESULTS
1. VALIDATION OF QUANTITATIVE RT-PCR METHOD (I)
Contamination either with genomic DNA or previously amplifi ed DNA can 
greatly affect the results because of the high degree of sensitivity of PCR based 
methods (Bristow et al. 1993). For these reasons, the total RNA of the samples 
and internal stardard cRNA were assessed for DNA remnants by performing 
PCR and RT reactions without reverse transcriptase. As expected, no amplifi -
cation products were seen. During measurements, RT and PCR reactions in-
cluded a negative control. When performing the RT and PCR and measuring 
the same sample 10 times the coeffi cient of variation was 13.9%.
2. THE EFFECT OF SHORT-TERM ETHANOL AND CALCIUM   
 CARBIMIDE TREATMENT ON APOPTOSIS AND EXPRESSION OF  
 CARDIAC MODULATORY GENES IN VIVO (II, IV)
In this study, 96 6-week old rats were divided into three groups (2-day, 5-
day and 8-day experiment) and each of these groups further to subgroups (C: 
control; E: ethanol 1g/kg of body weight daily; CC: calcium carbimide 100 
mg/kg of diet daily; E+CC: treated with both ethanol and calcium carbimide 
daily). High blood acetaldehyde levels were measured in all of the E+CC treat-
ment groups (Figure 2), but only in one ethanol treated group (2-day) was 
acetaldehyde concentration (2.1±1.6 µmol/l) detectable, although low. The 
blood samples for ethanol and acetaldehyde were taken 2 hours after ethanol 
injection and thus represent peak blood concentrations.
Total body weight growth was partly inhibited during combined E+CC 
treatment in all three (2-day, 5-day and 8-day) E+CC treatment groups com-
pared with respective control groups (p<0.001 in all). In 2- and 5-day experi-
ments calcium carbimide treatment alone also inhibited normal body weight 
increase (p<0.001) (Figure 3). The heart weight was lower in the E+CC treat-
ment group at 8 days compared with the respective control group (p<0.05) 
(Figure 3). Also calcium carbimide treatment alone had a negative effect on 
heart weight at 8 days (Figure 4), but the heart to body weight ratio did not 
change signifi cantly, neither did it change in any other experimental group 
(Figure 5).
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Figure 2.  Blood ethanol (EtoH) and acetal-
dehyde (AcH) concentrations after ethanol 
(E: 1 g/kg of body weight) or combined etha-
nol + calcium carbimide (CC: 100 mg/ kg of 
diet) treatment for 2, 5 or 8 days. Values are 
expressed as means.
Figure 3.  Total body weight increase af-
ter exposure to either ethanol (E: 1 g/kg of 
body weight), calcium carbimide (CC: 100 
mg/ kg of diet) or combined E+CC treat-
ment for 2, 5 or 8 days. Values are expressed 
as means. *** p<0.001 as compared with 
respective control group.
Figure 4.  Heart weights of control rats, 
and of rats after exposure to either ethanol 
(E: 1 g/kg of body weight), calcium carbim-
ide (CC: 100 mg/ kg of diet), or combined 
E+CC treatment for 2, 5 or 8 days. Values 
are expressed as means. * p<0.05, ** p<0.01 
as compared with respective control group.
Figure 5.  Heart weight to body weight ra-
tio in control rats and after exposure to ei-
ther ethanol (E: 1 g/kg of body weight), cal-
cium carbimide (CC: 100 mg/ kg of diet), 
or combined E+CC treatment for 2, 5 or 8 
days. Values are expressed as means. 
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Both ethanol and calcium carbimide treatments alone tended to increase 
the relative amount of apoptotic nucleosomes, but only combined E+CC treat-
ment at 5 days increased the index signifi cantly by 23% (p<0.05) compared 
with control rats (Figure 6).
Figure 6.   The amount of apoptotic nucleosomes in control rats (C), and af-
ter ethanol (E: 1 g/kg of body weight), calcium carbimide (CC: 100 mg/ kg 
of diet), or combined E+CC treatment at 5 days. Data are shown as means ± 
SEM. * p<0.05 as compared with the control group.
Combined E+CC treatment increased left ventricular ANP mRNA levels 
by 60% (p<0.05) at 2 days, and by 41% (p<0.05) at 8 days compared with 
respective control groups (Figures 7 and 8). On the other hand, BNP mRNA 
levels were not statistically signifi cantly changed in any of the experimental 
groups (Figures 7 and 8).
Combined E+CC treatment increased left ventricular p53 mRNA levels by 
15% at 8 days as compared with the controls (p<0.05), but this induction was 
not seen in other experimental groups (Figures 7 and 8).
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Figure 7.  (a) The effects of ethanol (E: 1g/kg of body weight), calcium car-
bimide (CC: 100 mg/kg of diet), and combined E+CC treatment on heart left 
ventricular mRNA levels of measured genes at 2 days. C= controls. Data are 
shown as means ± SEM. * p<0.05, ** p<0.01 as compared with respective 
control values. (b) Relative differences in mRNA expression of measured genes 
after ethanol (E: 1g/kg of body weight), calcium carbimide (CC: 100 mg/kg of 
diet), or combined E+CC treatment at 2 days. Values are expressed as % dif-
ference relative to respective mRNA level in control group. 
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Figure 8.  (a) The effects of ethanol (E: 1g/kg of body weight), calcium car-
bimide (CC: 100 mg/kg of diet), and combined E+CC treatment on heart left 
ventricular mRNA levels of measured genes at 8 days. C= controls. Data are 
shown as means ± SEM. * p<0.05, ** p<0.01 as compared with respective 
control values. (b) Relative differences in mRNA expression of measured genes 
after ethanol (E: 1g/kg of body weight), calcium carbimide (CC: 100 mg/kg of 
diet), or combined E+CC treatment at 8 days. Values are expressed as % dif-
ference relative to respective mRNA level in control group.
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No statistically signifi cant changes could be observed in p21 mRNA levels 
in either ethanol or calcium carbimide treated groups at 2 or 8 days, although 
calcium carbimide treatment lowered the level by –26% at 8 days. Combined 
E+CC treatment, however, increased the left ventricular p21 mRNA level by 
25% at 2 days (p<0.05) and, interestingly, decreased the level by 24% at 8 
days (p<0.05) compared with respective controls (Figures 7 and 8).
Bcl-2 mRNA levels remained quite constant at 2 days, but at 8 days, a 
36% increase was seen in the E+CC treatment group (p<0.05). On the oth-
er hand, bax mRNA levels were more than 30% higher in all experimental 
groups compared with respective control groups. However, only certain of 
these changes were statistically signifi cant, probably due to the relative small 
experimental groups. It is noteworthy, that the only group in which the bcl-2 
to bax ratio was signifi cantly decreased (by 36%; p<0.05) was the E+CC treat-
ment group at 2 days (Figures 7 and 8).
TNF-alpha mRNA levels tended to be lower in all experimental groups at 2 
days. However, none of these changes were statistically signifi cant (Figures 7 and 8).
3. THE EFFECT OF ACUTE ETHANOL AND ACETALDEHYDE   
 INFUSION ON APOPTOSIS AND EXPRESSION OF CARDIAC   
 MODULATORY GENES IN LANGENDORFF PREPARATION (III)
In this study, neither ethanol (5% v/v) nor acetaldehyde (500 µmol/l) infusion for 
150 min in Langendorff preparation induced any changes in the relative amounts 
of apoptotic nucleosomes compared with control group (Figure 9; III: Table 3).  
Figure 9. The amount of apoptotic nucleosomes in Langendorff preparation 
after infusion with vehicle (C), ethanol (E: 5% v/v), or acetaldehyde (A: 500 
µmol/l) for 150 min. Data are shown as means ± SEM. There were no statisti-
cally signifi cant differences between experimental groups.
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Figure 10. (a) The effects of ethanol and acetaldehyde infusion on heart left 
ventricular mRNA levels of measure genes. Isolated rat hearts were infused 
with either vehicle (controls), ethanol (5% v/v), or acetaldehyde (500 µmol/l) 
for 150 min. Data are shown as means ± SEM. * p<0.05 as compared with 
control group. (b) Relative differences in mRNA expression of measured genes 
after 150 min of ethanol (E: 5% v/v) or acetaldehyde (A: 500 µmol/l) infusion 
in Langendorff preparation. Values are expressed as % difference relative to re-
spective mRNA level in control group. 
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Ethanol infusion increased cardiac left ventricular ANP mRNA levels by 
38% as compared with the control group (p<0.05). On the other hand, acetal-
dehyde infusion had practically no effect on ANP mRNA levels. With respect 
to BNP mRNA levels, there were no signifi cant changes in either experimen-
tal group (Figure 10).
No signifi cant differences in p53 mRNA levels were observed between the 
three groups (Figure 10).
Ethanol treatment increased p21 mRNA levels signifi cantly by 41% as 
compared with controls (p<0.05), but this induction was not seen in acetalde-
hyde treated hearts (Figure 10).
The levels of the bcl-2 and bax mRNAs remained quite constant throughout 
the experiment. Similarly, there was not a marked change in bcl-2 to bax ratio in 
neither of the experimental groups compared with controls (Figure 10).
In the ethanol treated hearts the amount of TNF mRNA was 27% lower 
and in the acetaldehyde treated hearts 42% lower than in the control hearts 
but neither of these differences were statistically signifi cant (Figure 10).
4. THE EFFECT OF CHRONIC ETHANOL EXPOSURE ON   
 APOPTOSIS AND EXPRESSION OF CARDIAC MODULATORY  
 GENES IN FEMALE AND MALE RATS IN VIVO (V)
This 2-year study consisted of male and female rats, which were divided into 
ethanol-treated and control groups. The morning blood ethanol and acetalde-
hyde levels were measured 2 months before the experiment ended (V: Table 1). 
No differences were observed in blood ethanol or acetaldehyde levels between 
the male and female ethanol fed groups. Likewise the chronic low dose etha-
nol exposure had no effect on the heart weight to body weight ratios. On the 
contrary, the total body weights were dependent on both gender and ethanol. 
Body weights of the female rats were signifi cantly lower than the weights of 
the male rats (p<0.001) and the weights of the ethanol treated rats (ethanol 
fed male and female rats combined) were lower than the weights of the control 
rats (males and females combined) (p=0.042) (V: Table 1)
No signifi cant changes could be observed in the relative amounts of apop-
totic nucleosomes in ethanol treated groups in either gender as compared with 
respective controls (Figure 11). 
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No statistically signifi cant differences were seen in ANP and BNP mRNA 
levels between any of the groups studied (Figure 12). 
p53 mRNA levels were dependent on ethanol exposure (p<0.05) and gender 
(p<0.001). The chronic low dose ethanol treatment increased p53 mRNA levels 
in both males and females compared to their controls not exposed to ethanol. 
Interestingly, the p53 mRNA levels in males were higher (ethanol and control 
groups combined) than the p53 mRNA levels in females (ethanol and control 
groups combined) (Figure 12; V: Figure 1). 
In contrast to p53 levels the p21 mRNA levels were not dependent either 
on gender or ethanol (Figure 12). 
The levels of bcl-2 and bax mRNAs and the bcl-2 to bax ratios were not 
signifi cantly affected by either ethanol or gender (Figure 12). 
No statistically signifi cant differences were seen in TNF-alpha mRNA lev-
els between any of the groups studied (Figure 12).
Figure 11.  The amount of apoptotic nucleosomes in control rats (MC= male 
control group, FC= female control group) and after two years of ethanol ex-
posure in vivo (ME= male ethanol treated group, FE= female ethanol treated 
group). Data are shown as means ± SEM. There were no statistically signifi cant 
differences between experimental groups.
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Figure 12. (a) The effect of two years of ethanol exposure on heart left ven-
tricular mRNA levels of measured genes in male and female rats in vivo. Data 
are shown as means ± SEM. (b) Relative differences in mRNA expression of 
measured genes after two years of ethanol exposure in vivo. Values are ex-





1. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR   
 APOPTOSIS
Alcohol abuse is a major cause of non-ischemic cardiomyopathy in Western 
society (Piano 2002). The mechanism by which exposure to ethanol results in 
cardiac damage is unknown, but apoptosis, which clearly plays a role in etha-
nol-related injury of many other organs, may be involved. In the 150-minute 
study using a Langendorff preparation, no evidence was found that apoptosis 
occurred after ethanol or acetaldehyde infusion. Also exposure to ethanol alone 
for fi ve days or two years did not alter the degree of DNA fragmentation in 
vivo. In a study by Chen et al. (2000) using cultured neonatal cardiomyocytes, 
ethanol was found to increase apoptosis, dose-dependently. Prenatal exposure 
to ethanol has been found to increase myocardial apoptosis in rats (Ren et al. 
2002). In contrast, ethanol has a protective effect on heart muscle under some 
experimental circumstances (Miyamae et al. 1997; Krenz et al. 2002). In an 
experiment, in which rats that had been exposed for three weeks to ethanol 
before Langendorff preparation, infarct sizes were smaller and apoptosis less 
after ischemia-reperfusion of the ethanol-treated hearts than in controls that 
had not been exposed to ethanol (Sato et al. 2002). Treatment of hearts with 
low concentrations of ethanol (< 5 mmol/l) activates the cell-survival-promot-
ing pathway. Contrariwise, treatment with higher concentrations activates the 
pro-apoptotic pathway (Krenz et al. 2002). In the Langendorff experiment in 
the present study the ethanol concentration exceeded 5 mmol/l. However, the 
infusion time was only 150 minutes, which could have been too short for ap-
optosis to be triggered. In the developing rat forebrain, triggering of apop-
tosis by ethanol was found to require exposure to a concentration of at least 
43 mmol/l for four consecutive hours (Ikonomidou et al. 2000). In the study 
group in which rats received fi ve days of treatment with both ethanol and cal-
cium carbimide, blood ethanol concentrations were greater than 5 mmol/l, 
with concomitantly high blood acetaldehyde concentrations. In this group, the 
extent of DNA fragmentation was signifi cantly increased, refl ecting increased 
apoptosis. Acetaldehyde has been shown to accelerate apoptotic cell death and 
to inhibit cell growth in various other cells (Zimmerman et al. 1995; Holow-
nia et al. 1999). This fi ndings therefore support a role for ethanol and/or the 
acetaldehyde produced from ethanol in inducing apoptosis at high concentra-
tions in the heart. However, it cannot be concluded from our results whether 
ethanol, acetaldehyde or the combination of the two is the actual trigger of 
apoptosis. Also the direct effect of calcium carbimide itself remains unclear. 
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2. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR p53   
 GENE EXPRESSION
Exposure of an isolated heart to ethanol alone for 150 minutes and adminis-
tration of ethanol for two to eight days had no effects on p53 mRNA levels. 
There are reports in the literature that support both p53-dependent and p53-
independent mechanisms of ethanol-related apoptosis and growth suppression 
in various organs. In many instances, p53 has been shown to be regulated at 
the level of protein expression. In the present study p53 protein levels were 
not measured. The possibility that p53 plays a role in ethanol-related cardiac 
adaptation at earlier time points cannot therefore be excluded.
In this study, rats to which ethanol had been administered for two years ex-
hibited signifi cantly increased p53 mRNA levels, but no evidence of increased 
apoptosis was found. It has been shown previously that when p53 levels are 
elevated, cellular death does not always ensue (Hofseth et al. 2004; Slee et al. 
2004). Also, occurrence of cardiac apoptosis depends on the intensity of a par-
ticular stimulus (Kang & Izumo 2000). In the two-year study, levels of ethanol 
and acetaldehyde derived from ethanol were probably too low to cause detect-
able cell death. It is also possible that apoptosis played a more signifi cant role 
at earlier time points in the adaptation process. The reason for the observed 
increased heart p53 levels after ethanol exposure is not clear at present. Oxida-
tive stress increases p53 levels (Ueada et al. 2002) and oxidative stress has been 
implicated also in ethanol induced cell injury (Koch et al. 2002). Furthermore, 
acute ethanol exposure has been shown to induce oxidative stress in myocar-
dium (Kannan et al. 2004). It has also been suggested that p53 participates 
in sensing oxidative DNA damage (Achanta & Huang 2004). Normal diploid 
cells have limited potential for replication. The number of cell divisions pos-
sible is determined by the lengths of telomeres at chromosome ends. These 
shorten during each cell cycle. Once a critical length is reached, sensors for 
DNA damage are triggered and cell-cycle arrest or apoptosis is induced. p53 
seems to be important in relation to this response to telomere erosion (for ref-
erences see Igney & Krammer 2002). Interestingly, in mice, constitutive ex-
pression of p53 itself accelerates aging, and telomere loss (Tyner et al. 2002). 
The elevated levels of p53 mRNA seen in the two-year study could therefore 
have refl ected ethanol-induced stress reaction of the heart.
In the present study combined treatment of rats with ethanol and calcium 
carbimide for eight days resulted in higher p53 mRNA levels than in the con-
trols, and apoptosis after fi ve days. This fi nding is in accordance with earlier 
fi ndings suggesting that the p53 gene may play an important role in cardi-
omyocyte apoptosis (Leri et al. 1998b; Cesselli et al. 2001). Conversely, our 
data suggest that subacute exposure to ethanol or acetaldehyde derived from 
ethanol at particular concentrations may trigger the p53 gene in rat hearts, 
and that p53-dependent injury may be one mechanism in the development of 
AHMD.
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In the two-year study left ventricular p53 mRNA levels were approximately 
40% higher in male rats than in female rats irrespective of exposure to ethanol. 
Myocyte death in failing hearts has been shown to be gender dependent with 
higher propensity to myocyte death in male hearts. In human beings, it has been 
reported that myocyte loss is related to increasing age in men, but remains un-
changed with age in women (Guerra et al. 1999). Aging has also been shown to 
decrease telomerase activity in male rat myocytes but to increase the activity in 
female myocytes (Leri et al. 2000). In the human heart telomere loss leads to car-
diac dilatation and heart failure associated with up-regulation of p53 (Leri et al. 
2003). Therefore the observed gender dependence of p53 expression may be one 
factor explaining the differences in myocyte viability between genders in failing 
heart and during aging. However, in other cell and tissue types, results concern-
ing p53 levels relative to gender are confl icting (Toda et al. 1998; Zhao et al. 
2002; Natahara et al. 2003).
3. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR p21   
 GENE EXPRESSION
In the study using a Langendorff preparation, infusion of ethanol for 150 min-
utes increased p21 mRNA gene expression. p21 is a transcriptional regula-
tor of ANP (Kovacic-Milivojevic et al. 1997) and ANP induction was already 
evident at 150 minutes. In contrast, in vivo exposure of rats to ethanol for two 
days, eight days and two years had no statistically signifi cant effects on p21 
mRNA levels. It is possible that the p21 regulatory pathway does not play 
an important role at the later time points. The regulatory network also func-
tions differently in organ models and in vivo. However, p21 has been linked 
to cardiac hypertrophy by a number of investigators (Kovacic-Milivojevic et 
al. 1997) and results in the present study showing that infusion of a 0.5% 
ethanol solution into an isolated heart can markedly induce expression of p21 
and ANP genes is one of the fi rst direct pieces of evidence which links ethanol 
itself to a cardiomyocyte reaction related to cardiac hypertrophy.
In the study involving combined treatment with ethanol and calcium car-
bimide, p21 gene expression was 25% greater than in a control group after 
two days but 24% less after eight days. At fi ve days apoptosis was triggered. 
p21 regulates the cell cycle by inhibiting the cyclin-dependent kinases re-
quired for progression from the G1 to the S phase (El-Deiry et al. 1993) and is 
therefore important in relation to repair of damage to cell DNA (Cox 1997). 
p21 has been implicated in survival responses in a variety of systems in which 
exposure to stressful stimuli results in p53-independent cell death (Gorospe 
et al. 1997). In a study by Hauck et al. (2002), down-regulation of p21 was 
required for hypoxia-induced cardiomyocyte apoptosis to occur. In the present 
study, higher than normal p21 levels did not protect myocytes from apoptosis. 
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This result suggests that the high p21 mRNA levels seen after two days in the 
group treated with both ethanol and calcium carbimide may refl ect an attempt 
to diminish the environmental stress, at myocyte level. However, the DNA 
damage or biochemical stress resulting from exposure to ethanol or acetalde-
hyde derived from ethanol was too great to be overcome by p21 up-regulation, 
and that induction of apoptosis therefore ensued.
4. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR ANP   
 GENE EXPRESSION
It has been suggested that ANP gene expression is a sensitive indicator of car-
diac hypertrophic response (Chien et al. 1991). In the acute study using an 
isolated rat heart model, infusion of ethanol for 150 minutes signifi cantly in-
creased left ventricular ANP (and p21) gene expression. Other investigators 
have reported an increase in ANP tissue protein content 120 minutes after 
exposure to ethanol (Guillaume et al. 1994) or no change in mRNA and pro-
tein levels (Wigle et al. 1995). In the present study ethanol alone was capable 
of inducing genes involved in the regulation of cardiac hypertrophy, suggest-
ing that some aspects of alcoholic heart disease could be due to direct cardiac 
effects of ethanol rather than refl ect alterations in neurohumoral, hormonal or 
nutritional status. In contrast to the 150-minute experiment, no signifi cant 
change in ANP mRNA levels were detected after exposure of rats to ethanol 
for periods ranging from two days to two years. In other studies, six weeks of 
ingestion of ethanol has been found to increase ANP mRNA and protein lev-
els above those found in control rats (Wigle et al. 1993a) whereas two- or four-
month exposures have no effect (Kim et al. 2003). 
In the study using an isolated rat heart model, infusion of 500 µM acetal-
dehyde for 150 minutes had no effect on left ventricular ANP gene expression. 
Effects of acetaldehyde at a later stage cannot, however, be excluded. Treatment 
of rats simultaneously with both ethanol and calcium carbimide resulted in high 
blood acetaldehyde levels and ANP mRNA concentrations that were signifi cant-
ly higher than normal in the left ventricle wall. Elevated levels of expression of 
the ANP gene were detectable after only the second day of the treatment and 
remained evident after eight days of treatment. ANP protects against cardiac 
hypertrophy (Masciotra et al. 1999; Tamura et al. 2000) and the net effect of 
ANP on the myocardium in vivo is limitation of myocyte growth (Klinger et al. 
1993). ANP has been shown to induce apoptosis of cardiac myocytes, dose- and 
time-dependently (Wu et al. 1997; Kang et al. 2000). Five days of combined 
treatment with ethanol and calcium carbimide resulted in apoptosis. These fi nd-
ings suggest that high blood ethanol and/or acetaldehyde concentrations activate 
the gene encoding for ANP in rat ventricular myocardium, and that ANP might 
regulate apoptosis in the rat ventricular myocardium. Acetaldehyde could there-
fore play a role in relation to development of alcoholic heart disease. This notion 
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is supported by the results of a study by Liang et al. (1999). They found that 
acetaldehyde levels in mice hearts that over-expressed cardiac-specifi c alcohol 
dehydrogenase were four times greater after exposure to ethanol and that these 
hearts exhibited a high incidence of signs of alcoholic myocardial disease and sig-
nifi cantly increased ANP mRNA levels.
5. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR BNP   
 GENE EXPRESSION
In the present study, there were no consistent changes in cardiac BNP mRNA 
levels in any of the groups studied for 150 min to 2 years. This suggests that 
there was no sustained myocardial stretching, which stimulates BNP secretion 
(Ruskoaho 2003). It has been reported that administration of a 5g/kg dose of 
ethanol (40% w/v) to rats reduced left ventricular BNP mRNA levels to 38% 
of control levels after 120 minutes (Wigle et al. 1995). In studies lasting for 
six weeks or two, four or eight months, ethanol administration resulted in no 
changes in ventricular BNP gene expression (Wigle et al. 1993c;Guillaume et 
al. 1996b). Our fi ndings suggest that BNP was not involved in ethanol-in-
duced myocardial adaptation at the time points studied in the experiments.
6. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR BCL-2  
 AND BAX GENE EXPRESSION AND BCL-2/BAX RATIO 
Overexpression of bcl-2 protects cardiac myocytes against apoptosis (Kirshen-
baum & de Moissac 1997). In the present study, ethanol treatment alone had no 
effect on bcl-2 at any of the time points studied. Results reported in the litera-
ture on the effects of ethanol on bcl-2 levels and apoptosis in other tissues are 
confl icting. Bax, on the other hand, accelerates apoptosis in ventricular cells, and 
it can regulate apoptosis independently of bcl-2 (Regula et al. 2003). Eight days 
of treatment with ethanol alone increased bax mRNA levels. This fi nding fi nd-
ing suggest that ethanol regulates cardiac bax gene expression in vivo. Chen et al. 
(2000) have reported that ethanol increases bax protein levels dose-dependently 
in primary cardiomyocytes and decreases cell viability similarly. 
In the group treated with both ethanol and calcium carbimide bax mRNA 
levels were signifi cantly greater than in controls after two days. This was fol-
lowed by an elevated number of apoptotic nucleosomes after fi ve days. After 
eight days, bax gene expression was still being induced, and bcl-2 gene ex-
pression was also elevated. These fi ndings provide further evidence that the 
bax gene may be involved in ethanol- and/or acetaldehyde-induced apoptosis. 
The elevated expression of bcl-2 after eight days suggests that compensatory 
mechanisms become activated in an attempt to control apoptosis and maintain 
cell survival.
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The ratio of bcl-2 to bax can be regarded as a determinant of survival or 
death of ventricular cells (Reed 2002). In the present study the bcl-2/bax ratio 
after two days was signifi cantly lower in the rats treated with both ethanol 
and calcium carbimide than in the control group. In the developing rat CNS, 
prenatal exposure to ethanol lowered the bcl-2/bax ratio in the cortex, a fi nd-
ing in accordance with anatomical data relating to ethanol toxicity (Mooney 
& Miller 2001). It is possible that the lower than normal cardiac bcl-2/bax 
ratio after two days was an element in the mechanism leading to apoptosis af-
ter fi ve days. After eight days of ethanol exposure anti-apoptotic mechanisms 
were becoming activated as bcl-2 levels increased, and the bcl-2/bax ratio was 
at levels seen in controls. Ethanol and calcium carbimide were each capable on 
their own of increasing bax mRNA levels but their effects on the bcl-2/bax ra-
tio were not signifi cant. This fi nding supports the view that in some instances 
the bcl-2 to bax ratio is a better indicator of susceptibility to cardiac apoptosis 
than bcl-2 or bax mRNA levels alone.
There were no differences in bcl-2 and bax gene expression or the bcl-2/bax 
ratio between female and male left ventricles. In contrast, in cardiac fi broblasts 
basal protein levels of bcl-2 are higher in female rats than in male rats (Zhao et 
al. 2002). Toda et al. (1998) have reported that amounts of bcl-2 mRNA were 
higher in the lacrimal glands of female autoimmune mice than in the lacrimal 
glands of male autoimmune mice. No reports on the effects of gender on bax 
expression have been published. Results in this study suggest that there are no 
major gender differences as far as the aging rat heart is concerned in relation to 
bcl-2 or bax gene expression.
7. ETHANOL, ACETALDEHYDE AND LEFT VENTRICULAR 
 TNF-ALPHA GENE EXPRESSION 
TNF-alpha mRNA levels did not alter consistently in any of these experi-
ments. TNF-alpha is a pro-infl ammatory cytokine that has been associated 
with the genesis of numerous cardiovascular diseases, including heart failure 
(Feldman et al. 2000). There is also evidence that TNF-alpha plays a pro-sur-
vival role in the heart through regulation of adaptive responses to biomechani-
cal stress (Gill et al. 2002). The results suggest that TNF-alpha was not in-
volved in the mechanism of ethanol- or acetaldehyde-induced cardiac adapta-
tion under the circumstances studied. In contrast, ethanol has been found to 
affect TNF-alpha mRNA levels and signalling in other organs. In the liver, for 
example, TNF-alpha is required both for normal regeneration and in relation 
to ethanol-related liver damage (Diehl 1999).
Although amounts of TNF mRNA have been found to be higher in the 
lacrimal glands of female autoimmune mice than in the lacrimal glands of 
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male autoimmune mice (Rocha et al. 1998), no statistically signifi cant dif-
ferences in cardiac TNF-alpha mRNA levels between female and male rats 
were found.
8. LIMITATIONS OF THE STUDY
A major limitation of this study is that it is not possible to differentiate be-
tween the effects of ethanol and acetaldehyde in the group that was treated 
with both ethanol and calcium carbimide. It has been shown that treatment 
with concentrations of ethanol of < 5 mmol/l results in activation of path-
ways that promote cardiac cell survival, and that treatment with concentra-
tions of > 5 mmol/l activates pro-apoptotic pathways (Krenz et al. 2002). A 
concentration of 5 mmol/l was reached in all of the animal groups treated with 
both ethanol and calcium carbimide. In these groups acetaldehyde concentra-
tion was also high. It is therefore diffi cult to say whether the effects of ethanol, 
acetaldehyde or the two together caused the changes in apoptosis and gene 
expression detected. Also the direct effect of calcium carbimide itself remains 
unclear. Methods of studying the effects of acetaldehyde itself in vivo are dif-
fi cult due to its high toxicity.
Particularly in the two-year study, group sizes were small, and the number 
of experimental animals was limited. Also, in the two-year study, it would 
have been advantageous to determine p53 protein concentrations, since mRNA 
levels do not always refl ect changes at protein levels. Such experiments will be 
undertaken in future studies.
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SUMMARY AND CONCLUSION
Dilated heart failure is the leading cause of death in the elderly, particularly 
in elderly men. Alcohol abuse has been proven to be a major cause of non-
ischemic cardiomyopathy in Western society. However, neither the mechanism 
nor any specifi c toxic agent that results in alcoholic heart muscle disease has 
been established. During the last decade, roles played by apoptosis and apop-
tosis-regulating genes have been clearly described in relation to other ethanol-
induced organ damage, for example liver damage.
The key fi ndings in the study are:
1. A highly sensitive quantitative RT-PCR method was developed allowing 
determination of different mRNAs in very small amounts of cardiac tissue.
2. Combined ethanol and calcium carbimide treatment of rats for two to eight 
days resulted in high blood acetaldehyde levels, myocardial apoptosis and al-
tered expression of ANP, p53, p21, bcl-2 and bax genes. Whether the trigger-
ing molecule is ethanol or acetaldehyde formed from ethanol, or whether the 
changes observed result from the combined effects of both agents cannot be 
decided from the results of this study.
3. Acute ethanol infusion induced p21 and ANP gene expression in the iso-
lated perfused rat heart.
4. Chronic exposure to ethanol in vivo induced cardiac left ventricular p53 
gene expression. Expression of the p53 gene was also gender-dependent. Males 
had higher p53 mRNA levels than females. 
In conclusion, the results of this study indicate that ethanol and acetaldehyde 
may both be capable of regulating myocardial apoptosis and expression of 
genes associated with cardiac cell adaptation to stress. Although it must be 
borne in mind that mRNA levels do not always refl ect changes in protein lev-
els, our results shed new light on the basic mechanisms underlying the actions 
of ethanol and acetaldehyde on heart muscle.
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